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GLOSSARY 
ACT – activated clotting time is a bedside blood test to accurately measure the blood clotting 
time to guide heparin dosing during PCI or to ensure a safe level of clotting in order 
to remove an arterial sheath 
Ad hoc – not planned beforehand. In the context of coronary angiography and PCI, a 
coronary angiography procedure that then required PCI but was not planned 
beforehand. 
AngiosealTM (St. Jude Medical, Minnesota, USA) – see VCD 
Cardiac Advanced Trainee – a Medical Officer in training for Fellowship of the Royal 
Australasian College of Physicians (FRACP) specialising in Cardiology. 
Cardiologist – A Medical Officer with training in Cardiology and certification by the Fellowship 
of the Royal Australasian College of Physicians (FRACP). 
Elective PCI – PCI procedure performed on a non-urgent basis, with patients either admitted 
directly from home; or returning as an inpatient in the days following angiography or 
for pre-planned staged procedures. 
FemostopTM (St. Jude Medical, Plymouth, Minnesota, USA) - a mechanical compression 
device used to apply pressure over the femoral arterial puncture site to induce 
haemostasis. It consists of a reusable arch and pump with a manometer and a 
disposable dome, belt and stopcock. The pressure of the dome is controlled by the 
pump and manometer, and the arch and belt provide counter pressure for the dome. 
French size – International measurement used for catheters, sheaths and some other 
medical devices. 1 French size = 1/3mm (i.e. 9F = 3mm) 
Interventionalist - A Medical Officer with training in Cardiology and certification by the 
Fellowship of the Royal Australasian College of Physicians (FRACP), with a further 
1-2 years of interventional cardiology training. 
PCI – percutaneous coronary intervention is a generic term for any catheter-based treatment 
of coronary atherosclerotic disease, such as a balloon (PTCA), atherectomy or stent. 
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Primary PCI (or PPCI) – defined as PCI in the setting of STEMI (or presumed STEMI i.e. 
new left bundle branch block on ECG criteria) within 12 hours of symptoms onset, 
without previous fibrinolysis. 
Proceduralist – a Medical Officer performing a procedure, and in the context of this thesis, 
coronary angiography or PCI. A proceduralist may be a specialist cardiologist, or 
cardiac advanced trainee. 
PTCA – percutaneous transluminal coronary angioplasty  
SafeguardTM (Merit Medical, South Jordan, Utah, USA) - a manual compression assist 
device with strapping that secures to the patients skin, and contains a bulb which is 
inflated to 40mls to assist in the downward compression to achieve haemostasis. 
Sheath – a catheter device that is used to cannulate an artery (e.g. femoral, radial or 
brachial) or vein. A one-way valve allows for the insertion of coronary and other 
catheters for administration of contrast to visualise coronary arteries and cardiac 
chambers. The side-arm port allows for flushing, medication administration and 
arterial blood removal for ACT measurements. Sizes used at Gosford Cardiac 
Angiography Unit range from 5-French to 8-French. 
STEMI – ST elevation myocardial infarction 
Stent – a metal scaffold (usually containing cobalt and chromium) that is implanted into an 
atherosclerotic vessel to support the vessel wall and increase blood flow. Stents are 
either bare metal stents (BMS) or drug eluting stents (DES) with DES treated with an 
anti-cell prolific drug such as paclitaxel, zotarolimous and everolimous designed to 
slowly release over time inside a diseased vessel to inhibit restenosis. 
TR BandTM (Terumo Corporation, Shibuya-ko, Tokyo, Japan) – a radial artery compression 
device to assist in haemostasis. It consists of inflatable balloons within an adjustable 
wrist band and provides very specific compression to the radial artery while allowing 
continued ulna flow to perfuse the hand. 
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VCD – vascular closure device (e.g. Angio-SealTM) is a bioabsorbable plug that is inserted 
through a delivery system to seal the femoral artery puncture. 
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ABSTRACT 
Background: Peripheral vascular access site complications are known to occur following 
coronary angiography and percutaneous coronary intervention (PCI), and may range from 
small to severe. However, less is known of the prevalence of complications in the Australian 
context. The aim of this thesis was to determine the incidence and predictors for peripheral 
vascular access site complications following coronary angiography and PCI. 
 
Method: A retrospective evaluation was conducted on routinely collected data in an 
Australian public hospital following coronary angiography and PCI between 2007 and 2012. 
Backwards conditional logistic regression techniques were used to identify determinants of 
complications observed.  
 
Results: There were 3793 patient procedures analysed and most of the patients were male 
(n= 2408; 63.5%) with a mean age of 65.9 years (SD 12.2).  Complications were 
experienced by 46.5% (n= 1764); including haematoma (n= 586), bleeding (n=362) and 
bruising (n= 1690; 44.6%).  
 
Risk factors for haematoma were female gender with OR (95% CI) 1.41, (1.05-1.88), more 
than 1 arterial puncture (OR 2.19, 1.50-3.20) and pre sheath removal SBP of ≥ 140mmHg 
(OR 1.63, 1.22-2.17). Radial access (OR 0.24, 0.11-0.50) and diabetes (OR 0.65, 0.45-0.95) 
was associated with fewer haematomas.  
 
Risk factors for bleeding included PCI procedure (OR 3.54, 2.02-6.20) and history of 
hypertension (OR 1.81, 1.15-2.86). Lower risk factors for bleeding were radial access (OR 
0.10, 0.03-0.43) and later procedural year (OR 0.37, 0.18-0.78). 
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Risk factors for bruising were female gender OR 1.38 (1.16-1.63), PCI procedure (OR 2.24, 
1.38-3.65), more than 1 arterial puncture (OR 1.76, 1.37-2.26) and SBP of ≥ 140mmHg (OR 
1.46, 1.24-1.73); with radial access (OR 0.46, 0.34-0.61) and diabetes (OR 0.60, 0.49-0.74) 
associated with less bruising. 
 
The only identified risk factor for rare complications (n=39) (retroperitoneal bleeding, 
pseudoaneurysm, AV fistula, infection or requirement for vascular surgery) was female 
gender (OR 2.67, 1.29-5.53). 
 
Conclusion: The results from this evaluation provides insight into the frequency and risk 
factors for complications, and although serious complications were observed to be rare, less 
serious complications appear relatively common and are likely to be of great significance for 
patients undergoing future procedures. 
 
Keywords: coronary angiography, percutaneous coronary intervention, vascular 
complications, haematoma, bleeding, bruising, retroperitoneal bleed, pseudoaneurysm, 
arteriovenous fistula, infection, vascular surgery. 
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Chapter 1 - BACKGROUND 
 
1.1 Prevalence and diagnosis of coronary artery disease 
Cardiovascular diseases remain the leading cause of death in Australia, accounting for 
nearly 30% of deaths in 2012, and while ischaemic heart disease (IHD) was the leading 
underlying cause, the proportion of deaths due to this cause has decreased since 2003 
(Australian Bureau of Statistics, 2012). Invasive diagnostic and therapeutic procedure 
numbers have increased and may be associated with improved outcomes. Diagnostic 
angiography procedures in Australia increased from 78,390 in 2000-01 to 122,950 in 2012-
13, representing a 57% increase (Australian Institute of Health and Welfare, 2014c). There 
was also a 57% increase in percutaneous coronary intervention (PCI) procedures between 
2000-01 and 2007-08 (up to 155 per 100,000) (Australian Institute of Health and Welfare, 
2014b) although this fell slightly to 147 per 100,000 in 2012-13 (Australian Institute of Health 
and Welfare, 2014c). Over the past 4 decades Australia’s population has aged with a 3-fold 
increase in people greater than 65 years and a 6-fold increase in people over 85 years 
(Australian Institute of Health and Welfare, 2014a). Population projections (Australian 
Institute of Health and Welfare, 2014a) suggest the increased number and proportion of 
older persons are likely to result in a continued demand for coronary angiography and PCI.  
 
Coronary angiography and PCI procedures are usually well tolerated by most patients; 
however, accessing the arterial blood system is not without risk. Despite an in-hospital death 
rate of less than 0.2% for coronary angiography (Kern, 2011, p. 2) and 1% for PCIs 
(Australian Institute of Health Welfare, 2004), more common complications such as 
peripheral vascular access site complications are not routinely reported and prevalence is 
less understood in the Australian context. 
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1.2 Arterial access for coronary angiography and PCI 
Cardiac catheterisation was first performed in 1929, with Werner Forssmann passing a 
catheter into his own heart (Eeckhout et al., 2012a, p. 8). It wasn’t until decades later in the 
1960s and 1970s that cardiac catheterisation became a diagnostic procedure to evaluate 
haemodynamic and ventricular function as well as coronary anatomy (Carrozza, 2008). 
Cardiac catheterisation was originally performed by brachial cut-down (Franchi et al., 2009), 
a procedure that required a surgical skill set and longer procedural times. In 1952, Seldinger 
first described the percutaneous method of vascular access most commonly used today and 
since the 1980s this has become standard practice (Seldinger, 2008). 
 
Percutaneous access offers greater speed and fewer complications, and the lack of training 
for surgical cut-down techniques has also resulted in increased popularity for the 
percutaneous approach (Eeckhout et al., 2012a, p. 98; Watson & Gorski, 2005, p. 69). The 
most commonly utilised sites for arterial access are the brachial, femoral and radial sites. 
 
1.2.1 Brachial Access - The brachial artery approach evolved from the arterial cut-down 
method used in the pioneering era of interventional cardiology, and is rarely used in current 
practice (Eeckhout et al., 2012a, p. 69). The interest in brachial access resurfaced in the 
1990s when new device angioplasty procedures became commonplace and there was a 
concurrent increase in vascular complication rates with the femoral route. However brachial 
access was not advantageous compared to femoral access (Benit et al., 1997; Johnson et 
al., 1994). Brachial artery access is useful primarily when other routes fail or are 
contraindicated, however popularity has waned due to the risk of complications and difficulty 
with haemostasis (Kern et al., 2007, p. 175).  
 
1.2.2 Femoral Access - Arterial access via the femoral route has been the mainstream 
arterial angiography and PCI access site for over 2 decades (Jolly, Amlani, Hamon, Yusuf, & 
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Mehta, 2009). The large size of the femoral artery facilitates easy access (Kern et al., 2007, 
p. 173), with the average size of the right femoral artery 8.75 ± 2.11mm (Minami et al., 
2007). Femoral access allows larger diameter equipment for complex diagnostic and 
therapeutic techniques, is a better-known technique, easier to learn, and there is greater 
experience with both access and also management of complications compared with other 
arterial access routes (Franchi et al., 2009). 
 
1.2.3 Radial Access - The radial artery was first proposed as an access route for coronary 
angiography in 1974 (Eeckhout et al., 2012a, p. 56); although the first reported series of 100 
patients undergoing coronary angiography via the radial artery was not published until 1989 
(Campeau, 1989), and it had been slow to be adopted by others (Vavalle & Rao, 2009).  
 
There were many reasons radial access did not quickly supersede the more familiar femoral 
route. The radial artery is small in size compared to the femoral artery, usually between 1.8-
2.99mm (Amoroso, Laarman, & Kiemeneij, 2007; Loh et al., 2007) with men usually having a 
larger diameter than women (2.7 versus 2.4mm) (Caputo et al., 2011). There is an increased 
risk of spasm (resulting in severe pain) due to the smaller size of the radial artery and 
availability of catheter sizes and variety of interventional equipment is limited compared to 
femoral equipment (Cohen & Alfonzo, 2009; Franchi et al., 2009). There is also a longer 
learning curve in technical aspects involving radial arterial access, navigation of arterial 
vasculature and catheter manipulation for coronary cannulation (Cohen & Alfonzo, 2009; 
Franchi et al., 2009). These issues often lead to an increased procedural and fluoroscopy 
time, and subsequent radiation exposure – although this is not sustained once experience is 
gained (Amoroso et al., 2007). 
 
The radial approach has increased in popularity over the past decade with radial access 
surpassing femoral access in Europe, Asia and Canada (Eeckhout et al., 2012a, p. 56). 
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While it is the dominant route in these countries, it is estimated that worldwide, radial access 
accounts for approximately 22% of procedures (Caputo et al., 2011; Eeckhout et al., 2012a, 
p. 57). The rate of radial access uptake is unknown in Australia.  
 
The advantages of radial artery access for coronary angiography and PCI include improved 
patient comfort with immediate sheath removal and reduced need for prolonged bed rest; 
and by nature an easily compressible site allowing for decreased nursing care post 
procedure and early hospital discharge (Cohen & Alfonzo, 2009; Jolly et al., 2011; Tremmel, 
2009). 
 
1.3 Summary 
Ischaemic heart disease is the leading cause of mortality and morbidity in Australia, and 
there has been a concurrent increase in diagnostic and therapeutic procedures such as 
coronary angiography and PCI. These invasive procedures have traditionally been 
performed through the brachial and femoral artery, and more recently the radial artery has 
gained popularity. However, coronary angiography and PCI are not without risk. Peripheral 
vascular access site complications may occur relatively frequently and yet the prevalence in 
Australia in the current context is less understood. While complications such as haematoma, 
bleeding and bruising may seem innocuous, they can result in significant discomfort to the 
patient and even lead to death. 
 
In this thesis the incidence of peripheral vascular access site complications following 
coronary angiography and PCI in a single centre on the Central Coast of New South Wales, 
Australia is reported. This study also explores the various factors associated with peripheral 
vascular access site complications and may inform future preventative strategies to reduce 
the risk of these complications following invasive coronary angiography and PCI. 
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Chapter 2 - LITERATURE REVIEW 
 
2.1 Introduction 
In this chapter the prevalence of known peripheral vascular access site complications are 
described in detail as well as definitions for each complication from the literature discussed. 
Potential contributing risk factors are identified and categorised into patient demographic 
factors, past medical and medication history, procedural and post procedural factors. 
 
2.2 Prevalence of peripheral vascular access site complications 
There is an abundance of studies over the past 30 years reporting a variety of access site 
and non-vascular complications associated with coronary angiography, percutaneous 
transluminal coronary angioplasty (PTCA) and later, coronary stenting procedures. A review 
of more than 150 studies from 1973 to 2014 identified arterial access site complications 
including: haematoma, bleeding, bruising, retroperitoneal bleeding, pseudoaneurysm, 
arteriovenous (AV) fistula, complications resulting in vascular surgery and access site 
infection. The reported incidence of access site complications ranges considerably from less 
than 0.5% (Eggebrecht et al., 2004) to 76% (Chlan, Sabo, & Savik, 2005). Frequently, only 
large or severe complications are reported, with few studies reporting the full range of small 
to large, or seemingly minor to the most severe peripheral vascular access site 
complications (Table 1). In Table 1, key studies reporting more than 2 complications are 
reported from 34 studies from 1989 to 2013. 
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Table 1 Incidence of reporting peripheral vascular access site complications in reviewed studies reporting more than 2 complications 
Author and Year Sample size, 
n= 
Type Total Haematoma Bleed Bruise Retro-
peritoneal 
bleed 
Pseudo-
aneurysm 
AV fistula Vascular 
surgery 
Infection 
(Kaufman, Moglia, Lacy, 
Dinerstein, & Moreyra, 
1989) 
3,548 Angio/ PTCA 1.2% 0.6% NR NR NR 0.1% NR 0.42% 0.1% 
(Popma et al., 1993) 1,413 PCI 5.9% 2.8% (major –significant 
swelling + Hct ↓>10 points) 
NR NR 0.5% 2.1% 0.4% 3.0% 0.6% 
(Johnson et al., 1994) 1,579 PTCA 2.3% 1.3% (major-requiring 
surgery,  transfusion or ↑ 
LOS) 
NR NR 0.4% 0.4% NR 0.38% 0.1% 
(Moscucci et al., 1994) 688 PCI 11.7% 1.6% (incidence combined 
with bleeding > 10pt Hct↓) 
1.6% (incidence 
combined with  
haematoma) 
NR 1.7% 5.6% 1.5% 7.6% NR 
(Kussmaul 3rd et al., 
1995) 
435 Angio/PCI 15.4% 3.9% (any size, post 
procedure only) 
11% (any external 
blood loss, after VCD 
or  ≥ 30min MC) 
NR NR 2.8% 
(combined 
with AV 
fistula) 
2.8% 
(combined 
with PSA) 
0% 0% 
(Omoigui et al., 1995) 1,012 PTCA 6.6 5.2% (> 4cm) 1.5% (groin 
haemorrhage 
requiring transfusion) 
NR (Not 
defined, 
within 
bleeding) 
0.6% NR 1.4% NR 
(Kussmaul 3rd et al., 
1996) 
68 PTCA 16.2% 3% (any sized palpable 
measurable mass) 
13% (brisk visible 
bleed requiring MC) 
NR NR 0% 0% 0% 0% 
(Ward, Casale, Raymond, 
Kussmaul, & 
Simpfendorfer, 1998) 
304 Angio 8.2% 0% (> 6cm) 
4% (< 6cm) 
4.6% (late bleed) NR NR 0.7% NR 0.7% 0% 
(Carere et al., 1998) 204 Angio/ PCI 30.5% 1% (≥ 6cm) 
12% (< 6cm) 
2% (external overt 
bleed);  
NR NR 1.5% NR 5% 1.5% 
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7% (persistent ooze) 
(Pracyk et al., 1998) 778 PCI 64.7% 27.2% (> 4cm) 2.4% 27.6% NR 2.05% 0.8% NR NR 
(Warren, Warren, & 
Miller, 1999) 
238 Angio/PCI 45.3% 2.4% (≤ 6cm),  
0.8% (> 6cm) 
23.9% (persistent 
ooze 14%, brisk 
bleed req. MC 9% 
10% NR 0.4% NR 1.2% 0% 
(Amin et al., 2000) 150 PCI 27.3% < 5cm=6%,  
5-10cm=0%  
> 10cm=0% 
1.3% (sig. external 
blood loss e.g. 
required transfusion) 
19.3% NR 0.7% NR 0.66% NR 
(McCabe, McPherson, 
Lohse, & Weaver, 2001) 
306 Angio 11.4% 5.9% (minor) 
2.9% (major) 
4.2% (minor) 
0.3% (major -  
uncontrolled) 
NR (within 
major bleed) 
1.0% 0% 0% NR 
(Kapadia et al., 2001) 280 Angio 36% 33% (palpable mass) 2.5% NR NR NR NR 0.36% 0% 
(Duffin et al., 2001) 1,500 Angio/PCI 9.6% 7.7% (any “significant”) 2.1% (major - drop 
Hb 5mg/dl or 
transfusion) 
5.1% 0.13% 0.4% NR 0.67% 0.2% 
(Chandrasekar et al., 
2001) 
11,821 Angio/PCI 2.5%  
(1.8% angio, 
4% PCI) 
0.4% (≥ 10cm) 0.2% (≥ 3g/dL +/- 
transfusion) 
NR NR 0.7% 0.1% 0.2% NR 
(Walker, Cleary, & 
Higgins, 2001) 
274 PCI 23.6% 35.1% (> 2cm) 3.9% NR 0% 0.4% NR 0.4% NR 
(Dangas et al., 2001) 5,093 PCI 16.5% 7.6% 3.8% (Hct drop > 
15%) 
NR NR 1.2% 1.1% 1.8% NR 
(Schobel, Spyridopoulos, 
Hoffmeister, & Seipel, 
2001) 
150 PCI 4.5% 3.3% (≥ 2cm) NR NR NR 0.7% NR 0% NR 
(Applegate et al., 2002) 4,525 PCI 2.2% < 1% (>10cm) < 1% NR 0.6% 0.5% 0.2% 0.62% NR 
(Kinnaird et al., 2003) 10,974 PCI 11.2% Major 3.4% (> 4cm) 
Minor 7.5% 
NR NR 0.4% NR NR NR NR 
(Eggebrecht et al., 2004) 1,294 Angio/ stenting 0.5% 0% (major) 0.08% major (blood 
transfusion) 
NR 0% 0.15% NR 0.39% 0% 
(Tavris et al., 13,878 Angio 3.4% 2%(> 10cm) 1.3% (major – NR 0.2% 0.3% 0.02% 0.07% 0.03% 
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2005)(registry) transfusion, ↓Hb > 
3gm/dl, ↑LOS) 
(Chlan et al., 2005) 306 PCI 76% 20% (> 4cm) 19% (ooze) 37% NR 0.3% NR NR NR 
(Woodhead, Harding, 
Simmonds, Dee, & 
McBride-Henry, 2007) 
760 Angio/PCI 20% 16.1% 3.8% NR NR 0.1% NR NR NR 
(Buchler et al., 2008) 90 Stenting 8% 1.1% 3% NR 2% 1.1% NR 0% NR 
(Boztosun et al., 2008) 1,650 Angio 18.5% 4% (< 5cm) 
0.1% (> 5cm) 
1.7% (minor)  
0% major 
12.7% 0% 0% NR NR NR 
(Ramana et al., 2008) 1,422 Angio/ PCI 5.1% 2.5%  
(related to VCD failure) 
0.5% (requiring 
transfusion) 
NR 1.2% 0.5% 0.1% 0.14% 0% 
(Higgins, Theobald, & 
Peters, 2008) 
1,089 PCI 35.7% 13.1% 22.4% (bleeding or 
oozing) 
NR 0% 0.4% NR NR NR 
(Sanborn et al., 2010) 11,621 Angio/PCI 3% 1.8% (≥ 5cm) 0.6% (major-Surgical 
repair) 
NR 0.5% NR NR 0.6% NR 
(Sulzbach-Hoke, 
Ratcliffe, Kimmel, 
Kolansky, & Polomano, 
2010) 
413 PCI  16.5% 15.5%  
(1-5cm=8.5%, > 5cm=7%) 
1.5% (> 2g ↓ in Hb 
and/or blood 
transfusion – 
includes RPB) 
NR NR 0.7% 1% 0.73% NR 
(Jolly et al., 2011) 7,021 Angio/PCI 5.7% 2.1%  0.8% (major –↓Hb 
50g/L, requiring 
transfusion, or 
surgical repair 
NR 0.1% 0.4% 0.07% 0.01% NR 
(Burzotta et al., 2012) 10,676 PCI 0.5% 0.1% NR NR < 0.01% 0.09% 0.08% 0.06% 0.02% 
(Tewari et al., 2013) 26,238 Angio/PCI 2% 1% 0.07% NR 0.015% 0.05% 0% 0.05% NR 
NR = not reported 
Hct = haematocrit 
LOS = length of stay 
MC = manual compression 
Hb = haemoglobin  
PTCA = percutaneous transluminal coronary angioplasty 
PSA = pseudoaneurysm 
RPB = retroperitoneal bleed 
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2.2.1 Haematoma: Definitions of haematoma in the literature are diverse with some 
definitions comprising descriptions of the physical size of the complication, while others are 
limited to those complications that cause severe haemodynamic compromise such as a drop 
in haematocrit (Hct) or requiring blood transfusion or surgery to resolve (Table 1). The 
simplest definition is a palpable and measurable mass (Kussmaul 3rd et al., 1996). McCabe 
et al. (2001) extends this with a distinction between minor and major haematomas, defining 
a minor haematoma as “a collection of extravasated blood under the skin that forms a soft 
raised surface that is easily palpable”. A major haematoma is defined as the collection of 
extravasated blood that may or may not be palpable, occurring under the skin, in 
surrounding tissues, or extending into the retroperitoneum (McCabe et al., 2001). This may 
include retroperitoneal haematomas, which are commonly reported in the literature as a 
separate complication (Buchler et al., 2008; Duffin et al., 2001; Jolly et al., 2011). 
 
Haematomas may occur at any stage of the procedure from initial arterial puncture, during or 
after the procedure when haemostasis occurs, or in the hours or days following coronary 
angiography or PCI. The stages of development of a haematoma make early detection 
difficult, but as it progresses, it becomes easily identifiable in most instances. There is an 
initial soft spongy feeling on palpation of the area surrounding the arterial access site that as 
further blood collects, results in a hard painful lump (Watson & Gorski, 2005, p. 255). A 
further progression of the haematoma leads to increased thigh firmness that may extend 
downwards to the knee or lower, or alternatively, upwards into the peritoneal area. This 
progression may eventually lead to decreased distal pulses, lower extremity oedema, loss of 
sensory or motor function, impaired skin viability, tachycardia or shock, sometimes requiring 
surgical decompression (Kern et al., 2007, p. 173; Levine et al., 2003). However, 
haematomas may not always be easily identified. In obese patients, in whom significant 
blood loss may occur without obvious physical signs, haematomas may be difficult to 
appreciate (Wiley, White, & Uretsky, 2002). 
10 
 
An early American study compared peripheral vascular complications of diagnostic coronary 
angiography and PTCA via the femoral route (Kaufman et al., 1989). The investigators 
retrospectively reviewed 2904 diagnostic coronary angiography patients and 644 PTCA 
patients from 1984 to 1987 at a university hospital. The purpose of the study was to report 
non-cardiac complications and highlight the seriousness of these, given that scant attention 
had been paid to this type of complication in previous PTCA studies. Peripheral vascular 
complications were very low in the PTCA group (0.93%), which was less than the 
angiography group where 1.2% experienced complications. Of interest there were no 
haematomas in the PTCA group and only 0.6% in the angiography group. Despite variables 
which might explain an increase in vascular complications, the low rates of complications in 
this study were not explained. Reporting methodology, definitions and the retrospective 
nature of this study, may explain in part the low haematoma rates as peripheral vascular 
complications, including haematomas were not defined in the report. The inadequately 
defined definitions and methodology are in contrast to more contemporary studies where 
detailed definitions are presented and higher complication rates reported. 
 
In the early 1990s several studies identified major haematomas as an outcome variable, 
defined as large enough to cause significant clinical consequences to the patient (Table 1). 
One such study of 1413 patients sought to identify the incidence, predictors and outcomes of 
vascular complications (Popma et al., 1993). Major haematomas were reported in 2.8% of 
patients, with a total vascular complication rate of 5.9%. A major haematoma was defined as 
a significant swelling in the femoral region associated with a haematocrit (Hct) drop of more 
than 15 points from baseline. The authors describe haematomas as significant blood loss, 
associated traumatic injury to the artery, or the need for surgical repair. The low incidence 
may be attributed to methodological issues with an initial underestimation of complications 
due to exclusive definitions used to identify haematomas. 
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In contrast, some studies reported a high incidence of haematoma complications. One such 
study (Pracyk et al., 1998) defined haematomas as a nonpulsatile mass of greater than 4cm 
in diameter, and these occurred in 27.2% of patients. Several factors may have contributed 
to this increase in haematoma rates compared to that previously reported. While other 
studies conducted research using clinical practices common in that era, such as high 
anticoagulant doses, long sheath dwell times and larger sheath sizes; this was the first study 
to not only include independent physical examination of haematomas, but also 
ultrasonographic assessment in 50% of patients to provide validation of clinical 
assessments. The definition of haematoma, defined as being > 4cm by Pracyk et al. (1998), 
may further explain the higher incidence of reporting as a smaller haematoma may be more 
prevalent, whereas as other studies, have defined larger haematomas as >10cm,  report a 
much lower incidence (Applegate et al., 2002; Chandrasekar et al., 2001; Tavris et al., 
2005). 
 
Another study reporting a high incidence of haematoma from the similar era in 280 
diagnostic coronary angiography patients (Kapadia et al., 2001) defined haematoma size as 
either < 6cm requiring intervention or haematomas > 6cm.There was patient follow-up (either 
by clinical examination or by telephone) between 7-14 days post procedure which revealed a 
“palpable mass” in 33% of patients. The results of this study, despite a possible limitation of 
using patient self-assessment, may be attributed to less well-defined descriptors and a low 
threshold for reporting of, and hence high incidence for, haematomas.  
 
Overall, there is a wide variety in classifications of haematomas with all 34 studies in Table 1 
reporting a range of definitions resulting in difficult comparisons between studies. This was 
confirmed in a meta-analysis of 19 publications with a moderately large heterogeneity in 
definitions used to define haematomas (Koreny, Riedmuller, Nikfardjam, Siostrzonek, & 
Mullner, 2004). Definitions of haematomas have evolved over the past 3 decades, although 
12 
 
there is still no universally acceptable definition for a significant haematoma following 
coronary angiography and PCI. In the 1990s, common definitions encompassed a large 
haematoma with major clinical consequences such as requiring blood transfusions, vascular 
surgery or an increased length of stay (Johnson et al., 1994; Moscucci et al., 1994; Popma 
et al., 1993). However some reported “any sized” haematoma (Moscucci et al., 1994). More 
recently haematomas have been classified according to different sizes, such as ≥ 5cm or > 
10cm, or even < 6cm and ≥ 6cm diameter haematomas (Carere et al., 1998; Sanborn et al., 
2010; Tavris et al., 2005). This heterogeneity in definition of haematomas results in 
difficulties in the comparisons of prevalence between studies, especially from the 1990s to 
the present. 
 
2.2.2 Bleeding: Bleeding is the most visible of peripheral vascular access site complications 
and 28 of 34 studies reviewed report bleeding incidence which ranges from 0.07% (Tewari et 
al., 2013) to 23.9% (Warren et al., 1999)(Table 1). The simplest definition of bleeding was 
the leakage of blood from a puncture site (Pracyk et al., 1998). More complex definitions 
involved a specified drop in haemoglobin (Hb), a fall in Hct or administration of blood 
products (Duffin et al., 2001). 
 
Descriptive definitions often include some form of external visible bleeding (ooze, trickling, 
brisk or spurting blood) and efforts needed to control this, such as manual compression 
(Chlan et al., 2005; Kussmaul 3rd et al., 1996; McCabe et al., 2001). Quantitative definitions 
include a specified drop in blood count value such as a drop in Hb ≥ 3gm/dl (Applegate et 
al., 2002; Chandrasekar et al., 2001; Sanborn et al., 2010) or a drop in Hct by 10-15 points 
(Dangas et al., 2001; Moscucci et al., 1994). Finally, treatment-based definitions of bleeding 
require a response to the bleeding such as administration of replacement blood products as 
treatment for the bleeding complication (Amin et al., 2000; Ramana et al., 2008). Of the 28 
studies reporting bleeding in Table 1, the most frequent type of definition used was 
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descriptive, as illustrated in Figure 1 below. Another observation is that physician-led studies 
are more likely to define bleeding in quantitative or treatment-based terms than nursing-led 
studies (Figure 1). 
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Figure 1 Bleeding definitions according to the discipline leading the study 
 
Studies with a nursing focus are more likely to report a higher incidence of bleeding 
complications (Chlan et al., 2005; Higgins et al., 2008; Walker et al., 2001) compared to 
medical studies (Eggebrecht et al., 2004; Ramana et al., 2008) which may be due to 
differences in definitions. It is clinically easier to fulfil a descriptive definition such as 
“bleeding/ooze arising at the puncture site” (Higgins et al., 2008) than a quantitative 
definition of “bleeding resulting in a haemoglobin drop of ≥ 3g/dL” (Sanborn et al., 2010), 
which requires additional blood analysis leading to higher reported bleeding rates in studies 
with descriptive definitions. In an Australian, nursing-led study of 1089 patients post PCI 
(Higgins et al., 2008), the descriptive definition of bleeding resulted in a reported bleeding 
incidence of 22.4%. As the definition did not differentiate between arterial bleeding and 
venous ooze, the authors recommended caution as bleeding may at times have been 
venous tracking ooze rather than actual arterial bleeding, and the lack of clear definitions 
was acknowledged as a study limitation (Higgins et al., 2008). 
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In comparison to nurse-led studies, physician-led studies often report a low incidence of 
bleeding complications following coronary angiography and PCI. Of the 22 physician-led 
studies reporting bleeding in Table 1, over 80% had bleeding rates of less than 5%; 
significantly lower than the 22% reported by Higgins et al. (2008). The low incidence of 
bleeding complications reported by large medical studies show a continuing downwards 
trend occurring in the contemporary angiography and PCI era. A large British registry 
containing 46,128 high risk Primary PCI patients reported a 0.64% major bleeding event rate 
over a 5-year period (2006-2010), using a treatment-based definition of blood loss requiring 
blood transfusion or access site complication requiring surgery (Mamas et al., 2013). 
Similarly, Applegate et al. (2008), in a single-centre observational study of 35,016 
angiography and PCI patients reported a significant and downward trend of major bleeding 
defined by a > 3g/dl fall in Hb, over a 10-year period from 0.4% to 0% of patients. 
 
2.2.3 Bruising or ecchymosis: Bruising or ecchymosis at the vascular access site is less 
frequently reported in the literature compared to haematoma and bleeding complications 
(Table 1). Bruising is reported in only 6 out of the 34 studies presented in Table 1 and 
ranges from 5.1% (Duffin et al., 2001) to 37% (Chlan et al., 2005). Other studies reported an 
equal if not higher prevalence of bruising (between 36 and 68.6%) (Cheng, Chair, & Choi, 
2013; Cosman, Arthur, & Natarajan, 2011; Jaspers & Benit, 2003; Jones & McCutcheon, 
2003; Robb & McLean, 2000). While bruising is a relatively common complication it is the 
least researched peripheral access site complication. Vascular access site bruising is 
sometimes considered a minor complication and indeed an acceptable outcome following 
angiography or PCI; it is not a life threatening complication, usually does not prolong the 
patient hospital stay and there is no reliable method of measuring bruising (Cosman et al., 
2011).  
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Similar to bleeding, there are a variety of definitions used in studies which may reflect 
reports on bruising. In a very simple definition, a bruise is defined as any discolouration of 
the skin (Jones & McCutcheon, 2003), and also a presence of any skin discolouration 
without a mass (Chlan et al., 2005). A more detailed definition states bruising reflects the 
effects of bleeding into subcutaneous tissue planes (without a mass effect), causing a bluish-
purple discolouration (Pracyk et al., 1998). Furthermore, an Australian study by Botti et al. 
(1998) included swelling in the definition of bruising, a definition inconsistent with other 
studies (Chlan et al., 2005; Cosman et al., 2011; Pracyk et al., 1998). Unfortunately some 
authors do not provide definitions of bruising which may reflect assumptions about the 
obviousness of the complication or minimising the importance of such a complication when 
other complications were defined in detail (Amin et al., 2000; Boztosun et al., 2008; Duffin et 
al., 2001; Jaspers & Benit, 2003; Ludman et al., 1997). 
 
In addition to a variety of definitions for bruising, the classifications of bruising size are also 
highly variable and have evolved over time. Warren et al. (1999) defined bruising as any 
bruising ≥ 1cm2, but then omitted it from further analysis on the basis that bruising was not 
generally included in other studies (Warren et al., 1999). Botti et al. (1998) instructed 
patients to measure their bruise using a disposable tape measure to best approximate the 
size of their bruise and compare it to a page consisting of 3 drawings of bruising around the 
femoral site. Bruising size categories described small bruising as “local bruising”, moderate 
as extending down the anterior aspect of the thigh, and extensive bruising defined as 
bruising across the lower abdomen and buttocks (Botti, Williamson, Steen, McTaggart, & 
Reid, 1998). In a simpler method of describing bruising sizes, a Canadian nursing-led study 
classified the sizes of bruising into 4 groups, providing patient participants with examples of 
everyday objects against which to approximate bruise size (Cosman et al., 2011). Four size 
categories were described: a 25 cent coin (< 2.5cm), smaller than a golf ball (2.5-5cm), 
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smaller than a tennis ball (5-7.5cm) and larger than a tennis ball (> 7.5cm) (Cosman et al., 
2011). 
 
An important factor when assessing bruising appears to be time related, as bruising is not 
often immediately visible, unlike other complications such as bleeding and haematoma. Of 
the few studies that include bruising as a complication, there are a variety of methods when 
it comes to timing of assessment of bruising. In an early vascular closure device (VCD) study 
(Warren et al., 1999), 236 patients were assessed the morning after angiography or PCI. 
Only 10% of patients had bruising with no further follow up beyond discharge (Warren et al., 
1999). Therefore, the full extent in terms of size of the bruising or whether the bruising 
increased after discharge was not known. In contrast, in another study where patients were 
assessed at different time periods (pre-sheath removal, immediately post sheath removal, 
prior to mobilisation and at 5-days post procedure by follow up phone call post discharge), 
bruising incidence increased over follow-up time. Of patients who developed bruising post-
procedure 13% occurred after sheath removal, 15% developed prior to mobilisation and 50% 
had developed bruising by 5 days post-procedure (Jones & McCutcheon, 2003).  
 
Risk factors for bruising are less well known than haematomas and bleeding. Older age and 
a past history of hypertension was associated with bruising post PCI in one study (Sabo et 
al., 2008) and female gender was associated with bruising in several studies (Cheng et al., 
2013; Cosman et al., 2011). 
 
Despite the promise of radial arterial access resulting in fewer bleeding and access site 
complications, bruising has rarely been considered a complication when defining 
complications of radial procedures. Even the largest radial versus femoral multicentre RIVAL 
trial did not report bruising as an outcome variable (Jolly et al., 2011). In 2 studies that 
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defined bruising as a complication, both reported radial access being associated with the 
same incidence of bruising as femoral access (Cosman et al., 2011; Ludman et al., 1997).  
 
2.2.4 Rare complications: Retroperitoneal bleed: Retroperitoneal bleeding is a serious 
complication related to femoral arterial access in angiography and PCI. Mechanisms for the 
development of retroperitoneal bleeding include a high femoral puncture, posterior wall 
puncture, guidewire dissection or sheath perforation with injury to the external iliac artery or 
inferior epigastric artery that leads to bleeding tracking posteriorly into the retroperitoneal 
cavity (Eeckhout et al., 2012a, p. 62; Kern et al., 2007, p. 173). It is a potentially fatal 
complication as the retroperitoneum can harbour a large volume of blood with few external 
manifestations until hypovolaemia occurs, potentially leading to delayed recognition and 
treatment (Farouque et al., 2005). Mortality ranges from 4-12% and treatment commonly 
involves blood transfusions and vascular surgical repair (Eeckhout et al., 2012a, p. 62). 
 
The incidence of retroperitoneal bleeding is less than 1%. There is inconsistent inclusion of 
retroperitoneal bleeding as a peripheral vascular access site complication, with only 18 of 
the 34 studies reviewed reporting this complication. Two studies did not specifically define 
retroperitoneal bleeding, but may have been included under the bleeding category (McCabe 
et al., 2001; Omoigui et al., 1995). Large studies and registries containing more than 4000 
patients report an incidence of around 0.5% (Applegate et al., 2002; Kinnaird et al., 2003; 
Sanborn et al., 2010). Several smaller studies reported no incidence (Boztosun et al., 2008; 
Eggebrecht et al., 2004; Higgins et al., 2008; Walker et al., 2001) and others reporting > 1 to 
2% incidence of retroperitoneal bleeding (Buchler et al., 2008; Moscucci et al., 1994; 
Ramana et al., 2008). 
The true prevalence of retroperitoneal bleeding may be higher than reported, especially in 
registries which rely on robust routine reporting mechanisms. In addition, both Kent et al. 
(1994) and Farouque et al. (2005) suggest there may be uninvestigated subclinical 
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haemorrhage or wrong attribution of signs and symptoms (e.g. hypotension thought to be 
from dehydration), that are successfully treated with fluid resuscitation (Farouque et al., 
2005; Kent et al., 1994). 
 
Retroperitoneal bleeding as a complication following coronary angiography and PCI may be 
declining. The Mayo Clinic in North America evaluated trends associated with major femoral 
bleeding complications after PCI over a 10 year period (17,901 patients), broken down into 3 
time-period groups: group 1(1994-5), group 2 (1996-9) and group 3 (2000-5) (Doyle et al., 
2008) and reported that retroperitoneal bleeding rates fell significantly from 0.8% in 1994-5 
to 0.3% in 2000-5 (p<0.005). This reduction may be due to the increasing use of radial 
access over the traditional femoral access in recent years. Radial access has enabled the 
avoidance of the risks associated with the femoral artery puncture such as retroperitoneal 
bleeding. 
 
Risk factors for the development of retroperitoneal bleeding may include female gender, PCI 
versus diagnostic angiography, low platelet count, excessive anticoagulation (prolonged high 
APTT), and sheath removal protocol (delayed sheath removal or non-ACT guided sheath 
removal) (Kent et al., 1994). More recent studies suggest other emerging  risk factors such 
as use of vascular closure devices (VCDs), intravenous (IV) antiplatelet (glycoprotein IIb/IIIa 
inhibitor) use, low patient weight and high femoral puncture (Ellis et al., 2006; Farouque et 
al., 2005; Tiroch et al., 2008; Young et al., 2014). 
  
2.2.5 Pseudoaneurysm: Pseudoaneurysm is an uncommon complication that develops at 
the arterial puncture site following invasive procedures such as coronary angiography and 
PCI. A pseudoaneurysm forms when an arterial puncture site fails to seal, thus allowing 
arterial blood to ooze or jet into the extravascular space forming a pulsatile, aneurysm-like 
haematoma (Ates et al., 2006; Lenartova & Tak, 2003). Pseudoaneurysms may present as a 
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pulsatile haematoma, a new thrill or bruit and may be associated with marked tenderness or 
pain. Small pseudoaneurysms (< 2cm) seldom cause long-term sequelae, however  large 
pseudoaneurysms can cause ongoing pain, neuropathy secondary to femoral nerve 
compression, local skin ischaemia, or result in rupture, thrombotic or infectious emboli 
travelling downstream and compromise of distal circulation (Lenartova & Tak, 2003; 
Quarmby, Engelke, Chitolie, Morgan, & Belli, 2002; Samal & White, 2002). Asymptomatic 
and small pseudoaneurysms may be conservatively treated (and self-thrombose) and if 
symptomatic or large, may require ultrasound-guided compression, thrombin injection, 
covered stenting or vascular surgical repair (Knight, Healy, & Thomas, 2003; Quarmby et al., 
2002; Samal & White, 2002) 
 
Pseudoaneurysms occur rarely with the highest incidence of 5.6% in one study (Moscucci et 
al., 1994), however the vast majority of studies (22 of 34 reviewed) reported less than 1% 
incidence (Table 1). The incidence of pseudoaneurysms in the early era of coronary 
angiography and PCI was higher than more current research indicates and may be declining 
due to changes in clinical practice. An early large study of 13,203 diagnostic and 
interventional procedures over a 10-year period from 1980-1990 suggested an increasing 
pseudoaneurysm prevalence (Kim et al., 1992). While the pseudoaneurysm rate overall was 
0.55%, different time periods revealed pseudoaneurysms increased progressively from 
0.44% (1980-1987), to 0.59% (1987-1989), and 0.92% in 1990. In the following decade and 
beyond however, Applegate et al. (2008) found the trend in pseudoaneurysm rates in 35,016 
patients to be as low as 0.27%; this rate remained unchanged over a 10-year period (1998-
2007). Of the 25 studies reviewed showing a 0 to 1.00% pseudoaneurysm rate, nearly three-
quarters are from 2000 or later (Table 1), and it would appear that pseudoaneurysm rates 
via femoral access have stabilised at less than 0.50% (Table 1). Further declines may be 
possible with the increased use of radial access. The landmark RIVAL study (Jolly et al., 
2011) enrolled 7021 patients with Acute Coronary Syndrome to compare outcomes between 
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radial and femoral access for coronary angiography and PCI. They found pseudoaneurysms 
occurred significantly less frequently in the radial access group (0.20%) than the femoral 
group (0.60%), p=0.006 (Jolly et al., 2011). Other radial access studies also report a 
negligible incidence of < 0.1% (Burzotta et al., 2012; Tewari et al., 2013). The rarity of 
pseudoaneurysm in radial arteries is presumed to be due to the smaller calibre of the vessel 
(Caputo et al., 2011).  
 
Identified risk factors for the development of pseudoaneurysm include: failure to puncture 
over the femoral head, larger diameter sheaths, inadequate compression technique post 
sheath removal and abnormal haemostasis including that induced by prolonged use of 
anticoagulation, especially in the post-procedure period (Knight et al., 2003; Kresowik et al., 
1991; Moscucci et al., 1994; Quarmby et al., 2002). 
 
2.2.6 Arteriovenous (AV) fistula: AV fistula formation is a rare complication which results 
from puncture of the femoral artery as well as the vein, resulting in a fistulous communication 
between the 2 vessels. The majority of AV fistulas are small in size and immediate treatment 
is often not necessary due to the high likelihood of spontaneous closure (Kelm et al., 2002; 
Kern et al., 2007, p. 175; Samal & White, 2002; Wiley et al., 2002). Large or symptomatic AV 
fistulas however, can lead to serious clinical sequelae such as arterial insufficiency due to a 
steal phenomenon, congestive heart failure, deep vein thrombosis or a painful lower 
extremity (Nasser, Mohler, Wilensky, & Hathaway, 1995). AV fistulas that do not close 
spontaneously or are symptomatic can be successfully occluded with ultrasound-guided 
compression, covered stents, coil embolisation or vascular surgery (Kern et al., 2007, p. 
175).  
  
AV fistula is reported in only 15 of the 34 studies reviewed (Table 1) with the highest 
reported incidence 1.5% (Moscucci et al., 1994). The methodological issues described 
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previously with pseudoaneurysm studies also apply to AV fistulas, with decreased 
incidences reported in larger studies (Applegate et al., 2002; Jolly et al., 2011; Tavris et al., 
2005; Tewari et al., 2013). While studies with smaller sample sizes reported a higher 
incidence (Moscucci et al., 1994; Sulzbach-Hoke et al., 2010), there was generally a wide 
variability in incidence due to the rarity of this complication (Kresowik et al., 1991; Kussmaul 
3rd et al., 1996).  
 
The first study to prospectively investigate the incidence, long-term clinical outcomes and 
risk factors for the development of femoral AV fistula was conducted by Kelm et al. (2002). 
This large study of 10,271 patients undergoing coronary angiography and PCI reported a 
0.86% incidence of AV fistula. All patients were examined by medical staff before and the 
day-after the procedure, including auscultation of both groins, with special attention to a new 
continuous bruit post procedure. Other clinical suspicions of vascular complications leading 
to an ultrasound included presence of haematoma, pulsatile mass, atypical pain, or vessel 
thrombosis. When suspected, an ultrasound was performed to confirm presence of AV 
fistula. Follow-up of patients with AV fistula revealed 38% closed spontaneously and the 
authors concluded that conservative management for at least one year before consideration 
for active intervention appeared to be justified as serious outcomes such as limb damage 
and cardiac volume overload were highly unlikely (Kelm et al., 2002).  
 
Routine screening of all patients with ultrasound scanning following coronary angiography 
and PCI may reveal an increased incidence of subclinical AV fistulas. In an early study 
(1988-9) of 144 PTCA patients, routine ultrasound scanning of the groin resulted in a 2.8% 
reported incidence of AV fistulas (Kresowik et al., 1991). Duplex scanning performed only 
when clinical suspicions support AV fistula would likely result in lower reported incidence, 
and routine scanning in large patient populations is not feasible. However, scanning of 
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patients even with seemingly minor groin pathology for example, haematomas or atypical 
pain (Kelm et al., 2002), may still produce higher rates of AV fistulas. 
 
Risk factors for the development of AV fistulas are difficult to determine with the majority of 
studies combining complications and risk factors associated with several complications, not 
AV fistulas specifically. Some risk factors were reported to date include: female gender, 
arterial hypertension, high or low femoral puncture, multiple puncture attempts, left groin 
puncture, high procedural anticoagulation dose and warfarin therapy (Kelm et al., 2002; 
Waksman et al., 1995). The impact of changes in practice in coronary angiography and PCI 
in the current era, may have produced a lower incidence of AV fistulas with studies since 
2010 (Table 1) reporting either no incidence of AV fistulas (Tewari et al., 2013) or very low 
incidence with rates as low as 0.08% and 0.07% (Burzotta et al., 2012; Jolly et al., 2011). 
 
2.2.7 Complications resulting in vascular surgery: Vascular surgery for complications 
following coronary angiography and PCI may be indicated when the patient condition 
deteriorates secondary to a vascular complication or where the complication cannot be 
managed with less invasive measures. Indications for vascular surgery include large or 
symptomatic pseudoaneurysms, clinically significant haematoma, AV fistula, uncontrolled 
external bleeding, retroperitoneal bleeding, thrombosis, femoral artery dissection, groin 
abscess and mycotic aneurysms, vascular closure device (VCD) removal (e.g. AngiosealTM) 
and compartment syndrome (Burzotta et al., 2012; Duffin et al., 2001; Eggebrecht et al., 
2004; Kaufman et al., 1989; Lumsden et al., 1994; Sanborn et al., 2010; Warren et al., 
1999). 
 
Vascular surgery following coronary angiography and PCI was reported in 28 of the 34 
studies reviewed (Table 1), with an incidence of up to 7.6% (Moscucci et al., 1994). Over 
half of the 28 studies reporting vascular surgery note a ≤ 0.5% incidence, and since 2010 the 
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incidence of vascular surgery had further decreased to 0.01-0.06% (Table 1). Clinical 
practices in the early PCI era included aggressive and prolonged anticoagulation to prevent 
early stent thrombosis, intra-procedural thrombolytics, long sheath duration where sheaths 
were often removed the following day, large sheath sizes (commonly 8F, up to 11F) and new 
vascular closure devices (VasosealTM) which were being tested in the setting of continuous 
oral anticoagulation (Carere et al., 1998; Moscucci et al., 1994; Popma et al., 1993). 
 
Risk factors for the development of groin complications requiring vascular surgery were 
reported by Lumsden et al. (1994) in a prospective evaluation of 100 surgically treated 
vascular complications from 6,873 coronary angiography and PCI procedures. Types of 
complications requiring vascular surgery included pseudoaneurysms (61%), haematomas 
(11%), AV fistulas (10%), external active bleeding (6%), retroperitoneal bleeding (5%), 
thrombosis (3%), groin abscess (2) and mycotic aneurysm (1%) (Lumsden et al., 1994). Risk 
factors included older age, lower weight, female gender, stent insertion (compared to PTCA 
and atherectomy) and post procedure anticoagulation. The study was however, conducted in 
1990-1 in the early PCI-era and practices have evolved since that time. No study was found 
to investigate risk factors for patients requiring vascular surgery following coronary 
angiography and PCI in the current era or Australian context. 
 
2.2.8 Infection: Infection at the arterial access site is a rare but serious complication 
following coronary angiography and PCI. Types of infections include infected 
pseudoaneurysms and haematomas, groin abscesses and endarteritis (Cherr et al., 2001; 
Cooper & Miller, 1999; Pipkin, Brophy, Nesbit, & Mondy, 2000; Smith, Cruz, Moursi, & Eidt, 
2001). Signs and symptoms may involve pain, swelling, erythema, fever or chills, purulent 
discharge, raised white cell count and symptom onset frequently occurs after the patient is 
discharged. Common organisms found to cause infections at the femoral arterial access site 
include Staphylococcus aureus, followed by Staphylococcus epidermis, methicillin-resistant 
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Staphylococcus aureus, then Pseudomonas aeruginosa (Cherr et al., 2001; Cooper & Miller, 
1999; Kern et al., 2007, p. 175; Pipkin et al., 2000; Smith et al., 2001). Treatment ranges 
from antibiotic therapy to surgery for debridement, drainage and/or vessel reconstruction. 
 
Arterial access site infection following coronary angiography and PCI is a very rare 
complication with an overall 0-1.5% incidence (Table 1). However most of the 14 studies that 
reported infection in this review noted an incidence of infection < 0.3% (Table 1). The 
highest rate of infection of 1.5% was for a vascular closure device (VasosealTM) (Carere et 
al., 1998) which is no longer used clinically. 
 
Infection rates may have been underreported in studies as short follow-up periods may not 
reveal the delayed manifestation of signs and symptoms for infection. Patients may not 
present to the same hospital as their procedure or may present to their local doctor with 
milder infections successfully treated with oral antibiotics; infections may not be reported to 
the hospital where the procedure was undertaken. In 3 case reports of 10 patients with 
infections following coronary angiography or PCI, there was an average delay time of 11 
days (range 4-28 days) until patients sought help for symptoms (Cherr et al., 2001; Cooper & 
Miller, 1999; Pipkin et al., 2000). This was supported by Tavris et al. (2005) who referred to 
the limitations of their findings due to the limited period of follow-up, and concluded that most 
adverse events occur late. The United States Food and Drug Administration report of 
adverse events associated with the use of haemostasis devices (Tavris et al., 2005) points 
out that all 50 cases of infection occurred following discharge. 
 
Risk factors for the development of infection following coronary angiography and PCI include 
diabetes, repeated vascular access at the same site, long indwelling sheath time and 
vascular closure devices (VCDs) (Eeckhout et al., 2012a, p. 62; Samore, Wessolossky, 
Lewis, Shubrooks Jr, & Karchmer, 1997). The literature is equivocal regarding the risk of 
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infection with VCD use; while many studies report the safety of various VCDs with no 
significant increase in infection rates associated with their use (Chevalier et al., 2003; Kahn, 
Kumar, Hollander, & Frankel, 2002; Kapadia et al., 2001; Kussmaul 3rd et al., 1995), case 
report series consistently identify VCDs have an association with groin infections (Cherr et 
al., 2001; Cooper & Miller, 1999; Pipkin et al., 2000; Smith et al., 2001). 
 
There have been many changes in practice since the majority of VCD studies were 
conducted in the 1990s, and the incidence of infection rates following angiography or PCI in 
the Australian context is unknown. 
 
2.3 Peripheral vascular access site complications summary 
While serious complications associated with coronary angiography and PCI including death, 
stroke and myocardial infarction occur rarely, peripheral vascular access site complications 
occur more frequently but may be overlooked as they may be viewed less serious in nature. 
In this review of peripheral vascular access site complications, haematomas, bleeding, 
bruising, retroperitoneal bleeding, pseudoaneurysms, AV fistulas, complications resulting in 
vascular surgery and infection were discussed. Haematomas, bleeding and bruising 
occurred more frequently than the remainder of vascular complications. While haematomas 
and bleeding have been frequently included as a complication end point in the majority of 
studies, bruising is a more commonly occurring, but seldom-reported complication. This may 
be because it is seen as innocuous by many; however the patient may remember little about 
the experience of coronary angiography or PCI except for “the huge bruise afterwards”.  
 
Further complicating the reported incidence of peripheral vascular access site complications 
is the late onset of some of the complications, typically days or weeks. Studies which 
incorporated post discharge follow-up phone calls were in the best position to collect 
complications such as pseudoaneurysm, AV fistula, infection and particularly bruising (a 
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commonly occurring complication). Several studies involved follow up phone contact  that 
allowed for reporting of post discharge complications such as bruising (Boztosun et al., 
2008; Cosman et al., 2011) and swelling or bleeding at the access site (Kapadia et al., 2001; 
Ramana et al., 2008). However, reliance on patient-self reported complications may also be 
a limitation. There may be an over-reporting of complications with Kapadia et al. (2001) 
describing a 33% incidence of palpable mass, but not requiring an intervention for this 
complication at 7-14 days of follow-up. Several authors identified the importance of post 
discharge follow-up and described possible under-reporting of vascular complications as a 
potential limitation in their research (Burzotta et al., 2012; McCabe et al., 2001; Moscucci et 
al., 1994; Tavris et al., 2005). 
 
Several limitations are evident in previous studies reporting peripheral vascular access site 
complications. Multiple exclusion criteria may limit the generalisability of findings to patient 
populations that are similar to the reported study. Many of the studies reported in this 
literature review contain multiple exclusion criteria (Amin et al., 2000; Buchler et al., 2008; 
Chlan et al., 2005; Dangas et al., 2001; Kussmaul 3rd et al., 1996; Ward et al., 1998; Warren 
et al., 1999), however registries include all patients (Johnson et al., 1994; Tavris et al., 
2005). While new techniques, devices or protocols are trialled there is a risk of the higher 
risk patients being excluded. In a nurse led study of 306 patients designed to reduce bedrest 
periods, eliminate sandbags and provide patient comfort with early elevation of the head of 
the bed, multiple exclusion criteria included thrombolysis, glycoprotein (GP) IIb/IIIa inhibitors, 
PCI, large sheath size, delayed sheath removal and use of VCD or Femostop for 
haemostasis (McCabe et al., 2001). It may be difficult to apply the practice changes to higher 
risk patients and expect similarly low complication rates as reported by McCabe et al. 
(2001). In addition, sample size was identified as a limitation with insufficient statistical 
power to detect differences between patients with or without complications. Small sample 
sizes affected several studies limiting their ability to make definitive statements (Carere et 
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al., 1998; Duffin et al., 2001) or in the accurate reporting of very rare complications (Duffin et 
al., 2001). 
 
There is limited knowledge of the incidence of peripheral vascular access site complications 
in Australian practice, especially in the current era where practices have evolved and are 
continuing to change. 
 
2.4 Risk factors for peripheral vascular access-site complications 
Coronary angiography became an important diagnostic tool in the 1970s and there was an 
initial emphasis on non-vascular complications such as myocardial infarction, death, 
coronary occlusion and dissection, and emergency coronary artery bypass surgery. There 
was scant attention paid to vascular complications, which at the time were limited to 
thrombosis, embolism and pseudoaneurysm, and the causes for these were not discussed 
(Brener & Couch, 1973; Kennedy, 1982). Soon after the introduction of percutaneous 
transluminal coronary angioplasty (PTCA) in 1977 in the US, the National Heart, Lung, and 
Blood Institute established an international registry of PTCA patients to evaluate the safety, 
efficacy and long term effects of this new technique (Dorros et al., 1983). The reporting of 
complications again focused on the non-peripheral vascular types and risk factors for these 
were only briefly outlined. It wasn’t until other definitive therapies emerged that vascular 
complications began to assume importance; in particular, stenting in the 1980s was 
designed to treat acute occlusion and restenosis, and resulted in the subsequent need for 
high-dose anticoagulants to prevent subacute restenosis (Eeckhout et al., 2012a, p. 35).  
 
Several ground-breaking studies prior to 2000 reported the emerging increase of peripheral 
vascular access site complications and the risk factors associated with these (Moscucci et 
al., 1994; Muller, Shamir, Ellis, & Topol, 1992; Oweida, Roubin, Smith III, & Salam, 1990; 
Popma et al., 1993; Waksman et al., 1995). However, these early studies reported on the 
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combined peripheral vascular access site complications rather than individual complications, 
a limitation resulting in an inability to identify certain risk factors as being independently 
associated with the different complications. Since 2000, a number of studies have reported a 
range of risk factors as being independently associated with the various peripheral vascular 
access site complications (Table 2). 
 
Risk factors contributing to peripheral vascular access site complications reported in 
previous studies were grouped into patient demographics, past medical history, medications, 
procedural and post-procedural factors, and are presented in Table 2. Patient demographics 
including older age, BMI (both higher and lower BMI associated with complications) and 
female gender have all been identified as risk factors for the majority of access site 
complications (Table 2). Female gender was most strongly associated with females being 
1.5 to 8.6 times more likely to develop complications (Table 2). 
 
Past medical history has been associated with a variety of access site complications when 
combined as an endpoint, however fewer studies report associations with individual 
complications. A range of factors, including a history of hypertension, ischaemic heart 
disease (IHD), previous angiography or PCI, diabetes, peripheral vascular disease (PVD) 
and renal impairment have previously been associated with vascular complications as an 
combined endpoint (Applegate et al., 2008; Castillo-Sang et al., 2010; Doyle et al., 2008; 
Mathews et al., 2011). However, there is less evidence for medical history risk factors 
contributing to individual access site complications. There is an absence of studies reporting 
past medical history factors being associated with haematomas and access site infections, 
and only a few studies reporting an association between medical history factors with the 
remainder of complications (Table 2).  
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Numerous medications affecting platelets and clotting have been developed for primary 
prevention of cardiovascular diseases and also to prevent serious complications associated 
with PCI such as coronary thrombosis. However, they have in turn become risk factors for 
peripheral vascular access site complications. Antithrombotic medications have been 
strongly associated with peripheral vascular complications as a combined end point 
(Castillo-Sang et al., 2010; Louvard et al., 2004; Romaguera et al., 2012) but are less 
convincing regarding individual complications with only 4 studies reporting an association 
between antithrombotic medications and particular vascular complications (Table 2).  
 
Several procedural factors have been previously identified as being associated with the 
development of vascular access site complications. Risk factors included PCI (compared to 
angiography alone), radial access route (reduced risk compared to femoral), larger sized 
arterial sheath, left sided arterial access, multiple arterial punctures and long sheath dwell 
time, however they reported an association in only a few (1 -3) types of vascular 
complications (Table 2). Other factors previously reported to contribute to complications 
include level of experience of the doctor inserting the arterial sheath (Agostoni et al., 2006; 
Liew et al., 2007) and brachial artery access versus femoral access (Benit et al., 1997; 
Johnson et al., 1994) however these studies involved grouped vascular complications and 
the impact on individual complications was not discussed.  
 
Post procedural factors have not been shown to be consistent risk factors in the 
development of peripheral vascular access site complications following coronary 
angiography and PCI, with few studies reported in the post procedure factors section in 
Table 2.  Studies have shown a high systolic blood pressure (SBP) pre sheath removal as 
being associated with an increase in grouped complications (Dumont, 2007; May, Schlosser, 
& Skytte, 2009), however high SBP was not associated with individual complications (Table 
2). Vascular closure devices have been associated with both an increased and also a lower 
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risk of complications (Table 2). Experience of the person removing the sheath has not been 
identified as associated with an increased risk of complications (Table 2), however studies 
ensured only experienced staff remove sheaths to maintain consistency of practice and 
methodological rigor in research studies and the extent to which experience is a risk factor is 
not known.  
 
31 
 
Table 2 Studies reporting risk factors for the development of various peripheral vascular access site complications 
 Haematoma Bleeding Bruising Retro-
peritoneal 
bleed 
Pseudo-
aneurysm 
AV fistula Vascular 
surgery 
Infection 
Demographic         
Older age  HR1.04 (1.02-1.07) 
(Lansky et al., 2005) 
OR 1.03 (1.01-1.05) 
(Sabo et al., 2008) 
 
     
Body mass index 
(BMI) 
Lower BMI: 
OR 0.97 (0.96-0.99) 
(Dangas et al., 
2001) 
Body surface area 
OR 0.88 (0.80-0.98) 
(Sabo et al., 2008) 
 
Lower BMI: 
HR 0.11 (0.02-0.80) 
(Lansky et al., 2005) 
 Lower BSA: 
OR 7.05 (1.65-
30.02) 
(Farouque et al., 
2005) 
Lower weight 
(/kg): 
OR 0.987 
(0.976-0.997) 
(Ellis et al., 
2006) 
Higher BMI: 
OR 1.007 (1.003-
1.011) (Tavris et 
al., 2004) 
BMI ≥ 28kg/m
2
 
OR 2.21 (1.05-
4.51) (Ates et al., 
2006) 
 Lower BMI: 
OR 0.96 (0.94-
0.99) (Tavris et 
al., 2004) 
 
Female gender OR 2.6 (1.3-5.6) 
(Andersen, 
Bregendahl, 
Kaestel, Skriver, & 
Ravkilde, 2005) 
RR 1.45 (1.15-1.83) 
(Tavris et al., 2007)  
OR 4.40 (2.49-7.81) 
(Tizón-Marcos et 
al., 2009) 
OR 2.41 (2.19-2.65) 
(Tavris et al., 2004) 
HR 2.09 (1.19-3.68) 
(Lansky et al., 2005) 
RR 1.46 (1.08-1.96) 
(Tavris et al., 2007) 
OR 8.62 (2.11-
35.24) (Cheng et 
al., 2013) 
OR 6.40 (1.94-
21.13) (Cheng et 
al., 2013) 
OR 5.44 (1.66-
17.90) 
(Farouque et al., 
2005) 
OR3.73 (2.55-
5.43) (Ellis et al., 
2006) 
OR 2.62 (1.00-
6.80) (Knight et 
al., 2003) 
OR 2.40 (2.03-
2.85) (Tavris et 
al., 2004) 
RR 1.89 (1.06-
3.40) (Tavris et 
al., 2007) 
OR 1.84 (1.06-
3.20) (Kelm et 
al., 2002) 
 
OR 2.24 (1.67-
3.00)  (Tavris et 
al., 2004) 
 
Past medical 
history 
        
Hypertension   OR 0.53 (0.33-0.82) 
(Sabo et al., 2008) 
 
 OR 1.23 (1.02-
1.49) (Tavris et 
al., 2004) 
OR 1.86 (1.09-
3.17) (Kelm et 
al., 2002) 
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OR 1.52 (1.03-
1.90) (Ates et al., 
2006) 
 
Ischaemic heart 
disease 
    OR 1.21 (1.05-
1.22) (Ates et al., 
2006) 
   
Previous 
angiography/PCI 
        
Diabetes     OR 1.11 (1.06-
1.25) (Ates et al., 
2006) 
OR 1.73 (1.13-
2.65) (Tavris 
et al., 2004) 
  
Peripheral vascular 
disease 
 OR 1.22 (1.07-1.40) 
(Tavris et al., 2004) 
    OR 3.71 (2.74-
5.03) (Tavris et 
al., 2004) 
 
Chronic renal 
impairment 
 OR 1.48 (1.22-1.74) 
(Tavris et al., 2004) 
 RR 7.73 (Tiroch 
et al., 2008) 
OR 1.53 (1.11-
2.12) (Tavris et 
al., 2004) 
   
Medications         
Aspirin         
Clopidogrel         
Warfarin      OR 2.34 
((1.06-5.18) 
(Kelm et al., 
2002) 
  
Thrombolysis         
Pre-procedure 
heparin or LMWH 
OR 2.4 (1.0-5.3) 
(Andersen et al., 
2005) 
       
High procedural 
heparin dose 
      ≥ 12,500iu vs 
< 12,500iu 
OR2.88 (1.07-
7.73) (Kelm et 
al., 2002) 
  
Glycoprotein 
IIb/IIIa inhibitors 
   OR 1.92 (1.31-
2.82)  (Ellis et 
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al., 2006) 
RR 6.13 (Tiroch 
et al., 2008) 
Procedural factors         
Level of experience 
in sheath insertion 
        
Procedure –PCI vs 
angio 
 PCI vs angio OR 
2.64 (2.35-2.96) 
(Tavris et al., 2004) 
Stent vs PTCA HR 
1.78 (1.01-3.12) 
(Lansky et al., 2005) 
  PCI vs angio OR 
3.22 (1.24-8.33) 
(Knight et al., 
2003) 
PCI vs angio OR 
2.22 (1.82-2.66) 
(Tavris et al., 
2004) 
PCI vs angio 
OR 1.90 (1.20-
3.00) (Tavris 
et al., 2004) 
  
Arterial route: 
   Radial vs Femoral 
   Brachial vs 
Femoral 
Radial vs femoral 
OR 0.40 (0.28-0.57) 
(Jolly et al., 2011) 
   Radial vs femoral 
OR 0.30 (0.13-
0.71) (Jolly et al., 
2011) 
   
Large sheath size     ≥ 7F sheath size 
OR 2.82 (1.51-
5.25) (Ates et al., 
2006) 
   
Left vs right sided 
arterial entry 
     OR 2.21 (1.05-
4.65) (Kelm et 
al., 2002) 
 
  
Multiple punctures OR 2.7 (1.23-5.70) 
(Berry, Kelly, 
Cobbe, & Eteiba, 
2004) 
OR 3.4 (1.4-8.0) 
(Andersen et al., 
2005) 
      “Difficult 
vascular 
access” OR 
14.9 (2.1-
108.4) 
(Samore et 
al., 1997) 
Long sheath dwell 
time 
       Sheath 
duration > 1 
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day OR 6.8 
(1.3-35.9) 
(Samore et 
al., 1997) 
Post procedure 
factors 
        
High SBP pre 
sheath removal 
        
Method of sheath 
removal: 
   VCD vs manual 
   Mechanical vs 
manual 
compression 
VCD vs manual OR 
4.28 (2.07-8.88) 
(Dangas et al., 
2001) 
 
VCD vs manual OR 
0.85 (0.73-0.99) 
(Tavris et al., 2004) 
 
  No VCD used vs 
manual OR 10.2 
(2.03-52.6) 
(Knight et al., 
2003) 
VCD vs manual 
OR 0.46 (0.34-
0.64) (Tavris et 
al., 2004) 
 
   
Experience of 
sheath remover 
        
OR = Odds ratio 
RR = Relative risk 
HR = Hazard ratio 
(  ) = 95% Confidence Interval 
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2.5 Risk factors for peripheral vascular access site complications summary 
Coronary angiography and PCI procedures have evolved since the 1980s when PTCA 
followed by stenting was introduced, when procedures required high dose anticoagulation to 
treat the acute thrombosis and restenosis that subsequently occurred. It was then realised 
that non coronary complications such as peripheral vascular access site complications were 
a serious side effect of improved coronary outcomes. Various risk factors have been 
identified as being independently associated with a range of peripheral vascular access site 
complications over the past three decades. Potential contributing risk factors categorised 
into patient demographics, past medical and medication history, procedural and post 
procedural factors were presented in relation to specific complications and related to the 
current study. Available evidence was presented in Table 2, identifying the strength of 
demographic and past medical history factors as impacting the development of peripheral 
vascular access site complications. However, there is an opportunity for local research to 
contribute to the knowledge about peripheral vascular access site complications, especially 
in the Australian context. 
 
2.6 Study aims 
The primary aim of this study is to identify the incidence of various peripheral vascular 
access site complications following coronary angiography and PCI in an Australian public 
hospital population. A secondary aim is to determine the various factors (demographic, 
clinical and medication history, procedural and post procedural characteristics) associated 
with coronary angiography and PCI peripheral vascular access site complications. 
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Chapter 3 - METHODS 
 
3.1 Introduction 
In this chapter the study design is described in detail. Outcome variables are defined and 
data collection methods, instruments and database organisation outlined. Finally, data 
analysis methods used to test research aims are described. 
 
3.2 Research design 
This study is a retrospective evaluation and involved the analysis of routinely collected data 
for quality purposes between 2007 and 2012, and entered into a database. The study was 
undertaken to address the aims of identifying the incidence of various peripheral vascular 
access site complications in patients following coronary angiography and PCI, and to 
determine the factors associated with those complications. 
 
3.3 Subjects and setting 
The Central Coast Local Health District (CCLHD) located one hour north of Sydney, 
Australia covers an area of 1,769km2 and serves 328,646 people (Gosford City Council, 
2015; Wyong Shire Council, 2015). In this regional local health district, two acute hospitals, 
Gosford and Wyong accept cardiac patients. Gosford Hospital, a 500 bed, major referral 
hospital houses the only public Cardiac Angiography Unit (CAU) in the local district. The 
Gosford Cardiac Angiography Unit commenced operation in 2002 and performs 
approximately 1,200 procedures per year, of which the majority are diagnostic cardiac 
angiography, PCI and permanent pacemaker implantations. Rarely, other procedures 
performed include temporary pacing wire insertion, right heart catheterisation and intra-aortic 
balloon catheter insertion.  
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Patients are either referred on an outpatient basis for day-only diagnostic angiography or 
elective PCI with overnight stay in the Coronary Care Unit (approximately 50%), or are 
transferred for procedures as inpatients from either Gosford Hospital (approximately 30%) or 
Wyong Hospital (located 30km away) (approximately 20%). At present, the Cardiac 
Angiography Unit performs procedures 5 days per week, with procedural hours of operation 
from 8.30am to 4pm. The Central Coast does not have a twenty-four hour Primary PCI 
service, although Primary PCIs are performed during the hours of opening. 
 
3.4 Sample size 
The sample size for this study was based on data already contained in the local quality 
improvement database, collected between 2007 and 2012. There were 3,793 procedures 
involving 3,280 patients in whom coronary angiography and/or percutaneous coronary 
intervention had been performed, and 421 patients had multiple (i.e. 2 or more) procedures. 
This sample size was considered adequate to allow for valid statistical analysis.  
 
3.5 Ethical considerations 
Ethics approval was granted by the Northern Sydney Local Health District (NSLHD) Human 
Research Ethics Committee (HREC) and ratified by University of Sydney HREC as a low 
and negligible risk (LNR) project. 
 
The main ethical consideration related to this retrospective evaluation is data confidentiality. 
Confidentiality was maintained with all patient data stored on a secure local area network 
which was password protected and accessible only to the investigators. All patient data was 
de-identified. 
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3.6 Context to data collection and instrument used 
Prior to undertaking this retrospective evaluation as part of the Master of Philosophy degree, 
the author played a significant role in the audit design, data collection and data entry into a 
database for quality improvement purposes. The audit commenced in September 2007 and 
is ongoing, however for the purposes of this study the data collection period concluded in 
August 2012. The following summary provides a background to the context of this data 
collection. 
 
Patients gave verbal consent to participate in quality project and provided a contact phone 
number to nursing staff for follow-up. A standardised audit form was developed by a team of 
6 staff (including the author of this thesis) and used as the data collection tool (Appendix A). 
The audit form included patient characteristics such as gender, weight and height, age, 
inpatient versus outpatient status, and past history including hypertension, peripheral 
vascular disease (PVD), diabetes, previous angiography and PCI, ischaemic heart disease 
and chronic renal impairment.  
 
Pre-procedure variables were documented in the Cardiac Angiography Unit recovery area 
prior to the procedure and procedural variables were completed by the haemodynamic 
monitoring nurse during the procedure. Complications were identified and documented 
throughout the patient journey from intra-procedure to post discharge assessment by phone 
(within 2 weeks). Sheath removal was documented by nursing staff depending on the 
location of the patient, either in the procedure room, recovery or CCU.  
 
Throughout the audit period femoral sheaths were usually removed in the recovery area, 
where the registered nurse was responsible for choosing the method of sheath removal. 
Sheath removal occurred using the FemostopTM, manual compression or SafeguardTM 
according to local protocols. For patients who received a VCD, this was performed as part of 
39 
 
the procedure whilst the patient was in the procedure room. Patients having PCI via the 
femoral approach either received a VCD or were transferred to CCU, where the sheath was 
removed by CCU RNs approximately 4 hours after the last intra-procedure UFH dose was 
administered. 
 
Blood pressure was recorded pre sheath removal, either in-lab or in the CAU recovery or 
CCU depending on the location of the patient during sheath removal. Blood pressure was 
categorised according to National Heart Foundation guidelines of < 140mmHg and ≥ 
140mmHg, with ≥ 140mmHg being classified as hypertensive with escalating grades of mild, 
moderate and severe hypertension to ≥ 180mmHg (National Heart Foundation of Australia, 
2010). 
 
The audit form remained with the patient until discharge so that complications could be 
documented by nursing staff throughout the admission. After patient discharge, the audit 
form was returned to the CAU to enable follow-up phone contact approximately one week 
post discharge. Follow-up phone contact was successfully conducted with 83.6% patients 
(n=3,172). 
 
3.7 Outcome variable definitions 
Complications were documented as either present (yes) or not present (no) throughout the 
patients admission and at post discharge phone call. Complications included haematoma, 
bleeding, bruising, retroperitoneal bleed, pseudoaneurysm, AV fistula, vascular surgery and 
infection. Where patients had more than one complication, for example bleeding and 
haematoma and later bruising, these entered as separate complications. Patients with 
multiple complications were categorised as having had at least one complication. In Table 3 
definitions of complications reported in this thesis are presented. 
 
40 
 
Table 3 Definitions of complications 
Complication Definition Size/descriptor 
Haematoma A palpable mass at the puncture site caused from bleeding via 
the arteriotomy site 
Small < 5cm 
Moderate 5-10cm 
Large > 10cm                                 (Amin et al., 2000) 
Bleeding Ooze from the arteriotomy site, which may be arterial 
(pulsating) or venous (tracking ooze, not pulsating) 
Small – venous tracking, or arterial bleeding identified 
early and prevented from becoming large by immediate 
compression. 
Moderate – contained arterial bleeding 
Large – uncontained significant arterial bleeding 
Bruising Bluish purple colouring of the skin surrounding the arteriotomy 
site; a result of bleeding or haematoma formation 
Small < 5cm 
Moderate 5-10cm 
Large > 10cm 
Retroperitoneal 
bleeding 
Bleeding into the retroperitoneal cavity secondary to arterial 
puncture (Kern et al., 2007, p. 173) 
Diagnosed by computerised tomography (CT) scan 
Pseudoaneurysm A pulsatile mass at the arteriotomy site caused by the non-
healing of the arterial puncture site, leading to a false 
aneurysm (Kern et al., 2007, p. 174) 
Diagnosed by ultrasound or CT 
Arteriovenous (AV) 
fistula 
A communication between the femoral artery and femoral vein, 
causing a bruit (Sulzbach-Hoke et al., 2010) 
Diagnosed by ultrasound or CT 
Complications 
resulting in vascular 
surgery 
Any access site-related complication leading to vascular 
surgery, for example retroperitoneal bleed, thromboembolism, 
infection, uncontrolled haematoma or bleeding unable to be 
controlled by other methods, pseudoaneurysm, AV fistula, 
lacerated femoral artery, etc. 
 
Puncture site 
infection 
Redness, swelling and erythema at the puncture site which 
may result in fever and required antibiotics to resolve (Watson 
& Gorski, 2005, p. 256) 
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3.8 Data analysis 
Data were accessed from the quality improvement audit database (Microsoft ACCESS 2010 
Microsoft Corporation, Redmond, Washington, USA) and transferred to SPSS (IBM SPSS 
21 for Windows; IBM Corporation, Armonk, New York, USA) for statistical analysis. 
 
BMI was calculated using the formula kg/m2. Last date for administration of warfarin, 
thrombolysis, subcutaneous unfractionated heparin and low molecular weight heparin 
(LMWH) were calculated by the number of days since last dose and the procedure date. 
Similarly, time of cessation for intravenous heparin was calculated in minutes from cessation 
to sheath insertion. Arterial sheath dwell time was calculated in minutes from insertion to 
removal. Digital pressure in minutes for the initial haemostasis attempt was added to any 
subsequent period of digital pressure time to provide a total for digital pressure time. Last 
procedural heparin to sheath removal time was calculated in minutes.  
 
Due to the rare occurrence of rare complications (retroperitoneal bleeding, pseudoaneurysm, 
AV fistula, complications resulting in vascular surgery and puncture site infection); these 
were combined into one variable for valid statistical analysis. 
 
Incomplete patient data on the audit form was random and therefore treated as missing data.  
To address the primary study aim of identifying the incidence of various peripheral vascular 
access site complications in patients following coronary angiography and PCI, descriptive 
statistics for procedural, post-procedure and complications are presented with valid 
percentages for each variable. 
 
To identify univariate predicts of complications, comparison between groups with and without 
complications was performed using the Student’s t-test for interval data or chi-square test 
(χ2) for categorical data. Differences were considered statistically significant at p<0.05.  
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To identify associations between identified complications (haematoma, bleeding, bruising 
and rare complications) and patient demography, clinical characteristics and pre, intra and 
post coronary angiography and PCI procedures, linear regression analyses were performed. 
Identified significant univariate variables (at p<0.10) were entered into backward stepwise 
logistic multivariate regression models with probability of F-to-remove ≥ 0.10 until only those 
variables with p<0.05 remained in the model. Separate models were developed for each 
complication variable. 
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Chapter 4 - RESULTS 
 
4.1 Introduction 
In this chapter the patient population is described in detail, including demographic, clinical 
history and procedural factors associated with coronary angiography and PCI. Findings 
related to the primary study aim of identifying the incidence of peripheral vascular access 
complications (haematoma, bleeding, bruising, retroperitoneal bleeding, pseudoaneurysm, 
AV fistula, vascular surgery and infection) are then presented. Additionally, findings related 
to the secondary aim of determining factors associated with these complications are then 
detailed. Finally a table summarising the variables independently associated with 
complications is presented. 
 
4.2 Descriptive results 
4.2 1 Participant characteristics: Participant demographic and clinical history: The 
sample (n=3,793) was comprised of more men (63.5%) than women (36.5%) and the mean 
age was 65.9 years (Table 4). Almost three quarters of patients had a history of 
hypertension (72%), nearly half had a prior history of ischaemic heart disease (46.4%) and 
44.2% had previously undergone arterial access for angiography or PCI. A quarter of the 
patients had a history of diabetes (24.8%) and just over half (52%) of patients were admitted 
for their procedure directly from home (outpatients). 
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Table 4 Demographic and clinical characteristics 
Variable N (%)* 
Demographic 
   Age mean (SD) 65.9 (12.2) 
   BMIa mean (SD) 29.5 (6.3) 
   Sex  
      Male 
      Female 
 
2408 (63.5) 
1385 (36.5) 
Past medical history 
   Hypertension (medicated)       2855 (75.3) 
   Ischaemic heart disease 1760 (46.4) 
   Previous angiography/PCIb 1676 (44.2) 
   Diabetes  942 (24.8) 
   Peripheral vascular disease 644 (17.0) 
   Chronic renal impairment 521 (13.7) 
* results presented as n (%) unless otherwise stated 
a BMI= body mass index 
b PCI= percutaneous coronary intervention 
 
4.2.2 Medication history: Three quarters of patients were taking antihypertensive 
medications at the time of their procedure (Table 4). Over 80% of patients were taking 
aspirin and over half (55.8%) were taking the platelet inhibitor clopidogrel, either commenced 
in the acute setting or prescribed prior to hospital presentation (Table 5). For patients taking 
warfarin, the drug was ceased for an average of 5.5 days (range 1-35 days, SD 3.9) prior to 
the procedure. Pre-procedure mean INR was 1.4 (range 1.0-2.8, SD 0.3). 
 
Of patients who received thrombolytic therapy (n=109), 33% of these were thrombolysed on 
the procedure day, with the remainder having an average time of 2.1 days (SD 2.8) from 
thrombolysis to procedure. Patients receiving IV heparin (n=307) had the infusion ceased for 
a median time of 54 minutes (IQR 25.0-102.5 minutes) prior to arterial puncture time. Over a 
quarter (26.6%) of the patients received subcutaneous low molecular weight heparin 
(LMWH) or subcutaneous unfractionated heparin (UH) pre-procedurally, and of these, over 
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half (57.5%) had this medication ceased 24 hours prior to the procedure. Only 11% of 
patients receiving LMWH or subcutaneous UH were administered the medication within 24 
hours of their procedure. 
 
Table 5 Pre- or intra-procedural antiplatelet, anticoagulant and thrombolytic 
medications 
Variable N (%) 
Antiplatelet medications 
   Aspirin 3100 (81.7) 
   Clopidogrel 2115 (55.8) 
   IV a abciximab (ReoproTM) 46 (1.2) 
   IV a tirofiban (AggrastatTM) 15 (0.4) 
Anticoagulant medications 
   Warfarin 258 (6.8) 
   Pre-procedure IVa UFHb 307 (8.1) 
   Pre-procedure S/Cc LMWHd or UFHb 1008 (26.6) 
Thrombolytic therapy 
   Thrombolysis 109 (2.9) 
a IV= intravenous 
b UFH = unfractionated heparin 
c S/C = subcutaneous 
d LMWH = low molecular weight heparin 
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4.2.3 Intra-procedure characteristics: There were 3280 patients who underwent 3793 
procedures. The majority of patients had only one procedure over the study period (2007 to 
2012) (87.2%). Three hundred and forty-six patients (10.6%) had 2 procedures, 60 patients 
(1.8%) had 3 procedures, 13 patients (0.4%) had 4 procedures and only 2 patients (0.1%) 
had 5 procedures.  
 
Procedural characteristics are presented in Table 6. The majority of sheath insertions were 
performed by Cardiac Advanced Trainees (79.9%). Diagnostic angiography was the most 
frequently performed procedure (80.6%) followed by ad hoc PCI (i.e. a coronary angiography 
procedure that follows on to PCI but was not a planned PCI procedure beforehand) (10%), 
elective PCI (7%) and emergency primary PCI was performed in 2.3% of all procedures. 
 
The most common sheath size inserted was 6 French (69.1%) and the majority of sheaths 
were inserted on the patient’s right side (91.5%). Multiple arterial punctures (> 1 puncture) 
occurred in 10.3% of cases (Table 6). The vast majority of patients received intra-procedural 
heparin (92.3%) with a mean dosage of 2714 international units. 
 
Femoral artery entry was the most common route for performing procedures (Table 6). 
Access via the radial artery was performed in 23.4% of procedures in 2010, a noticeable 
increase from the previous year of 3.6% (Table 7). Femoral access steadily decreased from 
nearly 100% (in 2007) to less than 60% in 2012. The brachial artery was used for arterial 
access infrequently, with no change in frequency over the study period. Brachial access was 
only used if other routes were unsuccessful (2 procedures) or contraindicated (12 
procedures). 
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Table 6 Procedural characteristics 
Variable N (%) 
Doctor inserting sheath  
   Cardiologist  
   Advanced trainee  
   Missing 
 
758 (19.9) 
3029 (79.9) 
6 (0.2) 
Procedure type  
   Angiography 
   Ad hoc PCIa 
   Elective PCIa 
   Primary PCIa 
   Missing 
 
3058 (80.6) 
381 (10.0) 
264 (7.0) 
87 (2.3) 
3 (0.1) 
Route of arterial entry  
   Femoral 
   Radial 
   Brachial 
   Missing 
 
3177 (83.8) 
595 (15.7) 
14 (0.4) 
7 (0.2) 
Sheath size  
   5Fb 
   6Fb 
   7Fb 
   8Fb 
   Missing 
 
1141 (30.1) 
2620 (69.1) 
20 (0.5) 
6 (0.2) 
6 (0.2) 
Procedure side 
   Right 
   Left 
  Missing 
 
3472 (91.5) 
178 (4.7) 
143 (3.8) 
Multiple punctures 
   No 
   Yes 
   Missing 
 
3210 (84.6) 
391 (10.3) 
192 (5.1) 
Intra-procedural  IAc or IVd UFHe: 
   No UFH given 
   UFH given 
   Missing 
 
273 (7.2) 
3502 (92.3) 
18 (0.5) 
a PCI = percutaneous coronary intervention 
b F= French 
c IA = intra-arterial 
d IV = intravenous 
e UFH = unfractionated heparin 
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Table 7 Number of access routes per study year 
 2007* 
N (%) 
2008 
N (%) 
2009 
N (%) 
2010 
N (%) 
2011 
N (%) 
2012^ 
N (%) 
Femoral  273 (99.3) 
 
841 (97.9) 
 
835 (95.7) 
 
445 (76.5) 
 
479 (69.8) 
 
304 (59.5) 
Radial 1 (0.4) 
 
16 (1.9) 
 
31 (3.6) 
 
136 (23.4) 
 
205 (29.9) 
 
106 (40.3) 
Brachial 1 (0.4) 
 
2 (0.2) 
 
7 (0.8) 
 
1 (0.2) 
 
2 (0.3) 
 
1 (0.2) 
* Incomplete year. Represents last 4 months 
^ Incomplete year. Represents first 8 months 
 
4.2.4 Post-procedural characteristics: The majority of sheaths were removed by 
experienced Catheter Angiography Unit (CAU) nurses (46.2%) (Table 8). Cardiologists 
(11.9%) and advanced trainees (9.4%) removed femoral sheaths where vascular closure 
devices (e.g. AngiosealTM) were utilised. Mean systolic blood pressure prior to sheath 
removal was 137.2mmHg (SD 24.9). 
 
The most common method of achieving haemostasis following sheath removal was use of 
manual pressure (37%) requiring a mean compression time of almost 16 minutes (Table 8). 
In nearly all of the procedures performed by radial access, a TR BandTM was used for 
haemostasis. 
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Table 8 Post-procedural characteristics 
Variable N (%)* 
Sheath removed by 
   Medical Practitioners 
      Cardiologist 
      Advanced Trainee 
  Registered Nurses 
      Experienced CAU nurse 
      All other nurses 
   Missing 
 
806 (21.2) 
451 (11.9) 
355 (9.4) 
2957 (78.0) 
1754 (46.2) 
1203 (40.7) 
30 (0.8) 
Systolic blood pressure pre sheath removal 
   SBPc (range) 
   Missing  
 
137.2 (69-255) 
207 (5.5) 
Primary method of haemostasis 
   Digital 
      Time performed in minutes, mean (SD) 
   FemostopTM 
   Vascular closure device (eg. AngiosealTM) 
   TRTM band 
   Other (eg SafeguardTM) 
   Missing 
 
1402 (37.0) 
15.9 (10.7) 
990 (26.1) 
710 (18.7) 
582 (15.3) 
67( 1.8) 
42 (1.1) 
a PCI = percutaneous coronary intervention 
b CABGs = coronary artery bypass grafts 
c SBP = systolic blood pressure 
* results presented as n (%) unless otherwise stated  
 
 
4.3 Complications 
Nearly half (46.5%) of all procedures resulted in at least one peripheral vascular access site 
complication for patients, ranging from minor manifestations such as small bruising to major 
events such as retroperitoneal bleed (Table 9). Bruising was the most common vascular 
access site complication, experienced by patients during 44.6% of procedures, followed by 
haematoma (15.5%) and bleeding (9.5%). 
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Other peripheral vascular access site complications occurred rarely; pseudoaneurysms 
occurred in 0.4% of patients and retroperitoneal bleed, puncture site infections and 
complications resulting in vascular surgery each occurring in 0.2% of patients. No AV fistulas 
were documented. Thirty one patients had at least 1 ‘rare’ complications; 4 patients had 2 
complications and 2 patients had 3 complications.  
 
Table 9 In-hospital and post discharge complications 
Variable N (%) 
Any complication 
   Yes 
   No 
   Missing 
 
1764 (46.5) 
1700 (44.8) 
329 (8.7) 
Bruising (any size) 
   Small 
   Moderate 
   Large 
1690 (44.6) 
 749 (20.0) 
 388 (10.2) 
 543 (14.3) 
Haematoma (any size) 
   Small 
   Moderate 
   Large 
586 (15.5) 
359 (9.5) 
159 (4.2) 
68 (1.8) 
Bleeding (any size) 
   Small 
   Moderate 
   Large  
362 (9.5) 
233 (6.1) 
75 (2.0) 
54 (1.4) 
Rare complications (in-hospital or post 
discharge) 
   Pseudoaneurysm 
   Retroperitoneal bleed  
   Complication resulting in vascular surgery 
   Puncture site infection 
   Arteriovenous fistula 
 
 
16 (0.4) 
9 (0.2) 
7 (0.2) 
7 (0.2) 
0 
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4.4 Factors associated with haematoma 
Clinical history variables associated with haematoma are presented in Table 10. There was 
a higher incidence of haematomas in females, but a lower incidence for those with a history 
of diabetes, previous angiography or PCI, and a history of ischaemic heart disease. 
 
Table 10 Association between clinical history and risk of haematoma 
Variable Cases with 
haematoma 
(N=227) 
Cases 
without 
haematoma 
(N=3410) 
χ2 P value 
Clinical history 
Age mean (SD) 66.5 (12.2) 65.9 (12.2)  0.50 
BMIa mean (SD) 28.8 (5.8) 29.5 (6.0)  0.06 
Sex:   female n (%) 105 (46.3) 1226 (36.0) 9.736 0.002 
          male n (%) 122 (53.7) 2184 (64.0)   
Hypertension n (%) 161 (70.9) 2457 (72.1) 0.134 0.71 
Peripheral vascular disease n (%) 36 (15.9) 581 (17.0) 0.210 0.65 
Diabetes n (%) 39 (17.2) 857 (25.1) 7.247 0.007 
Previous angiography/PCIb n (%) 76 (33.5) 1522 (44.6) 10.748 0.001 
Chronic renal impairment n (%) 25 (11.0) 474 (13.9) 1.499 0.22 
Ischaemic heart disease n (%) 82 (36.1) 1598 (46.9) 9.875 0.002 
a BMI = body mass index 
b PCI  =percutaneous coronary intervention 
 
 
Pre-procedure medication history variables associated with haematoma are presented in 
Table 11. There was a higher incidence of haematomas in patients taking aspirin and for 
patients administered IV tirofiban. 
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Table 11 Comparison of patients with and without haematoma according to pre-
procedure medication history 
Variable Cases with 
haematoma 
(N= 227) 
Cases without 
haematoma  
(N= 3410) 
χ2 P value 
Pre-procedure medications 
Aspirin n (%) 197 (87.2) 2782 (81.7) 4.263 0.039 
Clopidogrel n (%) 124 (54.6) 1909 (56.1) 0.196 0.66 
Warfarin n (%) 12 (5.3) 235 (6.9) 0.857 0.36 
Warfarin days stopped pre 
procedure : mean (SD) 
7.36 (6.4) 5.41 (3.8)  0.34 
  
Antihypertensives n (%) 162 (71.7) 2571 (75.5) 1.686 0.19 
Thrombolysis n (%) 7 (3.1) 98 (2.9) 0.038 0.84 
Thrombolysis days pre procedure: 
mean (SD) 
0.50 (0.8) 2.21 (3.0)  0.17 
  
IVa UFHb n (%) 19 (8.4) 276 (8.1) 0.020 0.89 
IVa Heparin to sheath insertion time 
in minutes:  mean (SD) 
70.76 (99.6) 358.15 
(1379.9) 
 0.39 
  
s/cc LMWHd/UFHb n (%) 64 (28.3) 901 (26.5) 0.356 0.55 
s/cc LMWHd/UFHb last dose to 
sheath out in days: mean (SD)  
1.53 (1.5) 1.52 (1.7)  0.98 
  
Tirofiban n (%) 3 (1.3) 12 (0.4) 4.791 0.029 
a IV = intravenous 
b UFH = unfractionated heparin 
c s/c = subcutaneous 
d LMWH = low molecular weight heparin 
 
 
The year in which the procedure was performed and admission status are presented in 
Table 12. There was a higher incidence of haematomas in procedures performed in 2008 
compared to 2012. 
 
53 
 
Table 12 Comparison of patients with and without haematoma according to year of 
procedure and admission status 
Variable Cases with 
haematoma 
(N=227) 
Cases without 
haematoma 
(N=3410) 
χ2 AR P value 
Procedure 
Year of procedure:  
   2007 n (%) 
   2008 n (%) 
 
13 (5.7) 
80 (35.2) 
 
243 (7.1) 
759 (7.3) 
 
27.284 
 
-0.8 
4.5 
 
<0.001 
   2009 n (%) 57 (25.1) 794 (23.3)  0.6  
   2010 n (%) 31 (13.7) 536 (15.7)  -0.8  
   2011 n (%) 30 (13.2) 587 (17.2)  -1.6  
   2012 n (%) 16 (7.0) 491 (14.4)  -3.1  
Patient status:    
   Inpatient n (%) 
   Outpatient n (%) 
 
110 (48.5)  
117 (51.5) 
 
1633 (47.9) 
1777 (52.1) 
 
0.028 
  
0.87 
AR = adjusted residual: presented for variables with more than 2 categories 
 
Intra-procedure variables associated with haematoma are presented in Table 13. There was 
a significantly lower incidence of haematomas in patients with radial access procedures 
compared to femoral access, and a higher incidence for those with multiple arterial 
punctures. 
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Table 13 Comparison of patients with and without haematoma according to intra-
procedural variables 
Variable Cases 
with 
haematom
a (N=227) 
Cases 
without 
haematoma 
(N=3410) 
χ2 AR P value 
Intra-procedure 
Sheath inserter :    
   Cardiologist n (%) 
   Advanced trainee n (%) 
 
38 (16.7) 
189 (83.3) 
 
683 (20.1) 
2721 (79.9) 
 
1.478 
  
0.22 
Procedure type:   
   Primary PCIa n (%) 
 
3 (1.3) 
 
81 (2.4) 
 
5.375 
 
-1.0 
 
0.15 
   Elective PCIa n (%) 9 (4.5) 245 (7.2)  -1.8  
   Ad hoc PCIa n (%) 28 (12.3) 343 (10.1)  1.1  
   Diagnostic angiography n (%) 187 (82.4) 2738 (80.4)  0.7  
Route:        
   Femoral n (%) 
 
217 (95.6) 
 
2827 (83.1) 
 
28.888 
 
5.0 
 
<0.001 
   Radial n (%) 8 (3.5) 565 (16.6)  -5.2  
   Brachial n (%) 2 (0.9) 11 (0.3)  1.4  
Arterial puncture side:    
   Right n (%) 
 
200 (93.5) 
 
3125 (95.2) 
 
1.236 
  
0.27 
   Left n (%) 14 (6.5) 159 (4.8)    
Sheath size:      
   5Fb n (%) 
 
73 (32.2) 
 
1014 (29.8) 
 
0.690 
 
0.8 
 
0.71 
   6Fb  n (%) 152 (67.0) 2366 (69.5)  -0.8  
   ≥ 7Fb n (%) 2 (0.9) 24 (0.7)  0.3  
Multiple punctures (i.e. > 1) n (%) 39 (18.1) 340 (10.5) 12.041  0.001 
Total heparin dose mean (SD) 2632.1 
(1973.8) 
2725.9 
(2004.4) 
  0.50 
Abciximab n (%) 3 (1.3) 43 (1.5) 0.005  0.95 
AR = adjusted residual: presented for variables with more than 2 categories 
(%) = valid % presented for each variable 
a PCI = percutaneous coronary intervention 
b F = French 
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Post-procedure variables significantly associated with haematoma are presented in Table 
14. There was a higher incidence of haematomas in patients with a pre sheath removal 
systolic blood pressure ≥ 140mmHg and also with sheath removal using FemostopTM, but a 
lower incidence with vascular closure devices compared to manual compression. 
 
Table 14 Comparison of patients with and without haematoma according to post-
procedure variables 
Variable Cases with 
haematoma 
(N=227) 
Cases 
without 
haematoma 
(N=3410) 
χ2 AR P value 
Post-procedure 
Sheath dwell time minutes: 
mean (SD) 
51.19 (70.2) 50.97 (68.2)   0.21 
SBPa pre sheath removal:  
    ≥ 140mmHg n (%) 
 
118 (52.2) 
 
1392 (41.0) 
 
11.053 
  
0.001 
    < 140mmHg n (%) 108 (47.8) 2007 (59.0)    
Sheath remover:   
   Cardiologist n (%) 
 
21 (9.3) 
 
414 (12.2) 
 
3.723 
 
-1.3 
 
0.29 
   Advanced trainee n (%) 21 (9.3) 324 (9.6)  -0.2  
   CAUb experienced RNc n (%) 101 (44.5) 1578 (46.7)  -0.6  
   All other nurses n (%) 84 (37.0) 1068 (31.6)  1.7  
Haemostasis method:  
   Manual compression n (%) 
 
92 (42.2) 
 
1254 (44.5) 
 
8.846 
 
0.7 
 
0.031 
   FemostopTM n (%) 85 (39.0) 866 (30.7)  2.5  
   Vascular closure device n (%) 36 (16.5) 650 (23.1)  -2.2  
   Other n (%) 5 (2.3) 49 (1.7)  0.6  
AR = adjusted residual: presented for variables with more than 2 categories 
(%) = valid % presented for each variable 
a SBP = systolic blood pressure 
b CAU = Cardiac Angiography Unit 
c RN = registered nurse 
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To determine variables independently associated with haematomas, backward conditional 
logistic regression was used entering 12 significant (at p<0.10) univariate variables into the 
model. Eight variables were independently associated with haematoma (Table 15), 
accounting for 8.0% of shared variance (R2=0.080).  
 
Females were 1.4 times more likely to experience haematoma complications compared to 
males. Patients with diabetes or having a previous angiography or PCI procedure were 
significantly less likely to experience haematoma. Of the pre-procedure medications, aspirin 
and IV tirofiban were both associated with significantly more haematomas; patients taking 
aspirin were 1.7 times more likely to experience haematoma and those on tirofiban almost 6 
times more likely. 
 
Patients with radial access procedures were less likely to experience haematoma formation 
compared to those with femoral access procedures (Table 15). Patients with multiple arterial 
punctures were more than twice as likely to have bruising than patients with a single arterial 
puncture and patients with a systolic blood pressure of ≥ 140mmHg were also more likely to 
have a haematoma than patients with lower systolic pressures (Table 15). 
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Table 15 Multivariate predictors of haematoma complications 
Independent variable B (S.E.) P value Odds ratio 
(Confidence interval 
95%) 
Gender  - female 0.342 (0.148) 0.021 1.408 (1.054-1.882) 
History of diabetes - yes -0.427 (0.192) 0.026 0.652 (0.447-0.951) 
History of previous 
angiography/PCIa  - yes 
-0.412 (0.155) 0.008 0.662 (0.489-0.897) 
Year of procedure – 
   2008 vs 2007 
   2009 vs 2007 
   2010 vs 2007 
   2011 vs 2007 
   2012 vs 2007 
 
0.731 (0.390) 
0.307 (0.396) 
0.344 (0.416) 
0.324 (0.419) 
-0.070 (0.454) 
 
0.061 
0.438 
0.408 
0.438 
0.877 
 
2.077 (0.967-4.460) 
1.360 (0.626-2.953) 
1.411 (0.624-3.188) 
1.383 (0.609-3.143) 
0.932 (0.383-2.268) 
Route of arterial access –  
   Radial vs Femoral 
   Brachial vs Femoral 
 
-1.422 (0.377) 
0.838 (0.811) 
 
<0.001 
0.301 
 
0.236 (0.113-0.495) 
2.313 (0.472-11.340) 
Multiple punctures (> 1) 0.783 (0.193) <0.001 2.189 (1.498-3.197) 
SBPb ≥ 140mmHg 0.486 (0.147) 0.001 1.626 (1.218-2.170) 
Aspirin 0.509 (0.222) 0.022 1.664 (1.078-2.570) 
Tirofiban 1.733 (0.683) 0.011 5.658 (1.483-21.587) 
a PCI = percutaneous coronary intervention 
b SBP = systolic blood pressure 
 
 
4.5 Factors associated with bleeding 
Clinical history variables associated with bleeding are presented in Table 16. There was a 
higher incidence of bleeding in patients with a history of hypertension compared to patients 
without a history of hypertension. 
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Table 16 Comparison of patients with and without bleeding according to clinical 
history 
Variable Cases with 
bleeding 
(N=129) 
Cases 
without 
bleeding 
(N=3509) 
χ2 P value 
Clinical history 
Age mean (SD) 11.57 (11.6) 65.93 (12.2)  0.55 
BMIa mean (SD) 29.56 (5.5) 29.48 (6.0)  0.88 
Sex:    female n (%) 41 (31.8) 1290 (36.8) 1.330 0.25 
           male n (%) 88 (68.2) 2219 (63.2)   
Hypertension n (%) 104 (80.6) 2515 (71.7) 4.940 0.026 
Peripheral vascular disease n (%) 20 (15.5) 597 (17.0) 0.201 0.65 
Diabetes n (%) 25 (19.4) 871 (24.8) 1.985 0.16 
Previous angiography/PCIb n (%) 64 (49.6) 1534 (43.7) 1.756 0.19 
Chronic renal impairment n (%) 19 (14.7) 480 (13.7) 0.116 0.73 
Ischaemic heart disease n (%) 64 (49.6) 1616 (46.1) 0.634 0.43 
a BMI = body mass index 
(%) = valid % presented for each variable 
b PCI = percutaneous coronary intervention 
 
Pre-procedure medication history associated with bleeding is presented in Table 17. There 
was a higher incidence of bleeding in patients taking aspirin. 
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Table 17 Comparison of patients with and without bleeding according to pre-
procedure medication history 
Variable Cases with 
bleeding 
(N=129) 
Cases without 
bleeding 
(N=3509) 
χ2 P value 
Pre-procedure medications 
Aspirin n (%) 114 (89.1) 2865 (81.8) 4.437 0.035 
Clopidogrel n (%) 82 (63.6) 1951 (55.7) 3.090 0.08 
Warfarin n (%) 12 (9.4) 235 (6.7) 1.375 0.24 
Warfarin days stopped pre 
procedure : mean (SD) 
8.27 (8.1) 5.36 (3.6)  0.26 
Antihypertensives n (%) 103 (80.5) 2631 (75.1) 1.908 0.17 
Thrombolysis n (%) 7 (5.5) 98 (2.8) 3.116 0.08 
Thrombolysis days pre 
procedure: mean (SD) 
0.20 (0.5) 2.20 (2.9)  0.13 
IVa UFHb n (%) 16 (12.4) 279 (8.0) 3.226 0.07 
IV Heparin to sheath 
insertion time in minutes:  
mean (SD) 
111.3 (251.8) 
 
353.3 
 (1373.8) 
 0.50 
 
s/cc LMWHd/UFHb n (%) 30 (23.3) 936 (26.8) 0.784 0.38 
s/cc LMWHd/UFHb last dose  
to sheath out in days: mean 
(SD)  
1.3 (1.6) 1.5 (1.7)  0.48 
Tirofiban n (%) 0 (0.0) 15 (0.4) 0.558 0.46 
(%) = valid % presented for each variable 
a IV = intravenous 
b UFH = unfractionated heparin 
c s/c = subcutaneous 
d LMWH = low molecular weight heparin 
 
 
Comparing early procedure years (2007 and 2008) with later procedure years (2011 and 
2012), there was a higher incidence of patients with bleeding complications in 2007 and 
2008 compared to patients in 2011 and 2012 (Table 18).  
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Table 18 Comparison of patients with and without bleeding according to year of 
procedure and admission status 
Variable Cases with 
bleeding 
(N=129) 
Cases without 
bleeding 
(N=3509) 
χ2 AR P 
value 
Procedure 
Year of procedure:  
   2007 n (%) 
   2008 n (%) 
 
18 (14.0) 
40 (31.0) 
 
237 (6.8) 
800 (22.8) 
 
18.896 
 
3.1 
2.2 
 
0.002 
   2009 n (%) 29 (22.5) 822 (23.4)  -0.2  
   2010 n (%) 15 (11.6) 552 (15.7)  -1.3  
   2011 n (%) 13 (10.1) 605 (17.2)  -2.1  
   2012 n (%) 14 (10.9) 493 (14.0)  -1.0  
Patient status:  
   Inpatient n (%) 
 
64 (49.6) 
 
1680 (47.9) 
 
0.150 
  
0.70 
   Outpatient n (%) 65 (50.4) 1829 (52.1)    
AR = adjusted residual: presented for variables with more than 2 categories 
(%) = valid % presented for each variable 
 
Intra-procedure variables associated with bleeding are presented in Table 19. Patients 
having procedures involving elective PCI and ad hoc PCI had a significantly higher incidence 
of bleeding compared to patients having angiography alone. There was a higher incidence of 
bleeding in patients with larger sheath sizes, higher procedural heparin doses and abciximab 
administration. A lower incidence of bleeding occurred in patients with radial arterial access 
compared to femoral access. 
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Table 19 Comparison of patients with and without bleeding according to intra-
procedural variables 
Variable Cases with 
bleeding   
(N=129) 
Cases 
without 
bleeding   
(N=3509) 
χ2 AR P value 
Intra-procedure 
Sheath inserter: 
   Cardiologist n (%) 
   Advanced Trainee n (%) 
 
24 (18.8) 
104 (81.3) 
 
697 (19.9) 
2807 (80.1) 
 
0.101 
  
0.75 
Procedure type:   
   Primary PCIa n (%) 
 
3 (2.3) 
 
81 (2.3) 
 
20.446 
 
0.0 
 
<0.001 
   Elective PCIa n (%) 18 (14.0) 236 (6.7)  3.2  
   Ad hoc PCIa n (%) 23 (17.8) 348 (9.9)  2.9  
   Diagnostic angiography n (%) 85 (65.9) 2841 (81.0)  -4.3  
Route:        
   Femoral n (%) 
 
127 (98.4) 
 
2917 (83.3) 
 
21.087 
 
4.6 
 
<0.001 
   Radial n (%) 2 (1.6) 572 (16.3)  -4.5  
   Brachial n (%) 0 (0.0) 13 (0.4)  -0.7  
Arterial puncture side:   
   Right n (%) 
 
119 (96.0) 
 
3207 (95.0) 
 
0.228 
  
0.63 
   Left n (%) 5 (4.0) 168 (5.0)    
Sheath size:      
   5Fb n (%) 
 
33 (25.6) 
 
1055 (30.1) 
 
11.558 
 
-1.1 
 
0.003 
   6Fb n (%) 92 (71.3) 2426 (69.3)  0.5  
   ≥ 7Fb n (%) 4 (3.1) 22 (0.6)  3.3  
Multiple punctures (i.e. > 1) n (%) 9 (7.6) 370 (11.1) 1.400  0.24 
Total UFHc dose mean (SD) 3363.2 
(2549.3) 
2696.3 
(1975.7) 
  0.004 
Abciximab n (%) 6 (4.7) 40 (1.2) 11.972  0.001 
AR = adjusted residual: presented for variables with more than 2 categories 
(%) = valid % presented for each variable 
a PCI = percutaneous coronary intervention 
b F = French 
c UFH = unfractionated heparin 
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Post-procedure variables associated with bleeding are presented in Table 20. There was a 
higher incidence of bleeding in patients with longer arterial sheath dwell times and bleeding 
was also associated with the use of FemostopTM for haemostasis compared to manual 
compression. 
 
Table 20 Comparison of patients with and without bleeding according to post-
procedure variables 
Variable Cases with 
bleeding 
(N=129) 
Cases 
without 
bleeding 
(N=3509) 
χ2 AR P value 
Post-procedure  
Sheath dwell time minutes: mean 
(SD) 
93.6 (115.3) 50.2 (65.8)   <0.001 
SBPa pre sheath removal:  
   ≥ 140mmHg n (%) 
 
60 (46.1) 
 
1450 (41.5) 
 
1.304 
  
0.25 
   < 140mmHg n (%) 69 (53.5) 2047 (58.5)    
Sheath remover:  
   Cardiologist n (%) 
 
17 (13.2) 
 
416 (12.0) 
 
5.132 
 
0.4 
 
0.16 
   Advanced Trainee n (%) 13 (10.1) 332 (9.5)  0.2  
   CAUb experienced RNc n (%) 48 (37.2) 1632 (46.9)  -2.2  
   All other nurses n (%) 51 (39.5) 1101 (31.6)  1.9  
Femoral haemostasis: 
   Manual pressure n (%) 
 
42 (33.1) 
 
1304 (44.8) 
 
11.870 
 
-2.6 
 
0.008 
   FemostopTM n (%) 57 (44.9) 894 (30.7)  3.4  
   Vascular closure device n (%) 26 (20.5) 660 (22.7)  -0.6  
   Other n (%) 2 (1.6) 52 (1.8)  -0.2  
AR = adjusted residual: presented for variables with more than 2 categories 
(%) = valid % presented for each variable 
a SBP = systolic blood pressure 
b CAU = Cardiac Angiography Unit 
c RN = Registered nurse 
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Using backwards conditional logistic regression techniques, five variables were 
independently associated with bleeding (Table 21) accounting for 7.7% of shared variance 
(R2=0.077). 
 
Patients with a history of hypertension were almost twice as likely to have bleeding 
complications as patients without. Patients undergoing elective PCIs and ad hoc PCI were 
more than 3 times as likely to have bleeding complications as those having angiography 
alone.  Patients having procedures in 2009, 2010 and 2011 had between a 56.1% and 
62.7% lower risk of bleeding than patients having procedures in 2007. Patients who 
underwent their procedure by radial access were 90% less likely to have bleeding 
complications compared to femoral access and patients with longer sheath dwell times were 
also more likely to experience bleeding (Table 21). 
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Table 21 Multivariate predictors of bleeding complications 
Independent variable B (S.E.) P value Odds ratio 
(Confidence interval 
95%) 
History of hypertension 0.592 (0.233) 0.011 1.808 (1.145-2.855) 
Year of procedure: 
   2008 vs 2007 
   2009 vs 2007 
   2010 vs 2007 
   2011 vs 2007 
   2012 vs 2007 
 
-0.544 (0.300) 
-0.863 (0.315) 
-0.824 (0.363) 
-0.985 (0.378) 
-0.623 (0.373) 
 
0.070 
0.006 
0.023 
0.009 
0.095 
 
0.580 (0.322-1.045) 
0.422 (0.228-0.782) 
0.439 (0.215-0.894) 
0.373 (0.178-0.783) 
0.536 (0.258-1.115) 
Procedure type –  
   Ad hoc PCIa vs angiography 
   Elective PCIa vs angiography 
   Primary PCIa vs angiography 
 
1.241 (0.266) 
1.264 (0.286) 
0.792 (0.622) 
 
<0.001 
<0.001 
0.203 
 
3.459 (2.053-5.827) 
3.540 (2.020-6.204) 
2.208 (0.652-7.473) 
Route of arterial access 
   Radial vs femoral 
   Brachial vs femoral 
 
-2.273 (0.725) 
-17.921 
(12080.468) 
 
0.002 
0.999 
 
0.103 (0.025-0.427) 
0.000 (0.000) 
Sheath dwell time 0.005 (0.001) <0.001 1.005 (1.003-1.006) 
a PCI = percutaneous coronary intervention 
 
 
4.6 Factors associated with bruising 
Clinical history variables associated with bruising are presented in Table 22. There was a 
higher incidence of bruising in patients with a lower BMI and in females, but a lower 
incidence for those with a history of diabetes, previous angiography or PCI, and a history of 
ischaemic heart disease. 
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Table 22 Comparison of patients with and without bruising according to clinical 
history 
Variable Cases with 
bruising 
(N=931) 
Cases 
without 
bruising 
(N=2707) 
χ2 
 
P value 
Clinical history 
Age mean (SD) 65.5 (12.5) 66.1 (12.0)  0.47 
BMIa mean (SD) 28.9 (5.6) 29.67 (6.1)  <0.001 
Sex:   female n (%) 398 (42.7) 934 (34.5) 20.300 <0.001 
          male n (%) 533 (57.3) 1773 (65.5)   
Hypertension n (%) 656 (70.5) 1961 (72.4) 1.345 0.25 
Peripheral vascular disease n (%) 155 (16.6) 462 (17.1) 0.086 0.77 
Diabetes n (%) 162 (17.4) 734 (27.1) 35.216 <0.001 
Previous angiography/PCIb n (%) 347 (37.3) 1251 (46.2) 22.487 <0.001 
Chronic renal impairment n (%) 111 (11.9) 388 (14.3) 3.401 0.07 
Ischaemic heart disease n (%) 364 (39.1) 1316 (48.6) 25.245 <0.001 
a BMI = body mass index 
(%) = valid % presented for each variable 
b PCI = percutaneous coronary intervention 
 
Pre-procedure medication history associated with bruising is presented in Table 23. There 
was a lower incidence of bruising in patients taking antihypertensive medications. In patients 
administered an IV heparin infusion pre-procedurally, those associated with a higher 
incidence of bruising had a shorter duration of time between infusion cessation and 
procedure commencement. 
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Table 23 Comparison of patients with and without bruising according to pre-
procedure medication history 
Variable Cases with 
bruising 
(N=931) 
Cases 
without 
bruising 
(N=2707) 
χ2 P value 
Pre-procedure medications 
Aspirin n (%) 777 (83.5) 2202 (81.5) 1.922 0.17 
Clopidogrel n (%) 545 (58.6) 1488 (44.1) 3.382 0.07 
Warfarin n (%) 62 (6.7) 185 (6.9) 0.033 0.86 
Warfarin days stopped 
pre procedure : mean 
(SD) 
5.0 (2.6) 5.7 (4.3)  0.31 
Antihypertensives n (%) 663 (71.2) 2069 (76.6) 10.990 0.001 
Thrombolysis n (%) 33 (3.6) 72 (2.7) 1.191 0.17 
Thrombolysis days pre 
procedure: mean (SD) 
1.6 (2.7) 2.3 (3.0)  0.29 
IVa UFHb  n (%) 88 (9.5) 207 (7.7) 2.944 0.09 
IVa UFHb to sheath 
insertion time in minutes:  
mean (SD) 
 
135.0 (495.1) 
 
431.0 
(1566.4) 
 0.023 
s/cc LMWHd/UFHb n (%) 245 (26.4) 720 (26.7) 0.037 0.85 
s/cc LMWHd/UFHb last 
dose to sheath out in 
days: mean (SD)  
1.4 (1.3) 1.6 (1.8)  0.39 
Tirofiban n (%) 6 (0.7) 9 (0.3) 1.622 0.20 
(%) = valid % presented for each variable 
a IV = intravenous 
b UFH = unfractionated heparin 
c s/c = subcutaneous 
d LMWH = low molecular weight heparin 
 
Patients having procedures in 2011 and 2012 had a significantly lower risk of bruising 
complications compared to patients having procedures in 2008 and 2009 (Table 24).  
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Table 24 Comparison of patients with and without bruising according to year of 
procedure and admission status 
Variable Cases with  
bruising 
(N=931) 
Cases 
without 
bruising 
(N=2707) 
χ2 AR P value 
Procedure 
Year of procedure:     
   2007 n (%) 
   2008 n (%) 
 
72 (7.7) 
265 (28.5) 
 
184 (6.8) 
574 (21.2) 
 
74.135 
 
1.0 
4.5 
 
<0.001 
   2009 n (%) 261 (28.0) 590 (21.8)  3.9  
   2010 n (%) 141 (15.1) 427 (15.8)  -0.5  
   2011 n (%) 118 (12.7) 499 (18.4)  -4.0  
   2012 n (%) 74 (7.9) 433 (16.0)  -6.1  
Patient status:    
   Inpatient n (%) 
 
459 (49.3) 
 
1285 (47.5) 
 
0.932 
  
0.33 
   Outpatient n (%) 472 (50.7) 1422 (52.5)    
AR = adjusted residual: presented for variables with more than 2 categories  
(%) = valid % presented for each variable 
 
Intra-procedure variables that were associated with bruising are presented in Table 25. 
There was a higher incidence of bruising for patients having Primary PCI compared to 
diagnostic angiography, left sided arterial access, multiple arterial punctures, higher 
procedural heparin dose and abciximab administration. A lower incidence of bruising in 
patients was associated with radial arterial access compared to femoral access procedures. 
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Table 25 Comparison of patients with and without bruising according to intra-
procedural variables 
Variable Cases with 
bruising 
(N=931) 
Cases 
without 
bruising 
(N=2707) 
χ2 AR P value 
Intra-procedure 
Sheath inserter:  
   Cardiologist n (%) 
   Advanced Trainee n (%) 
 
169 (18.2) 
761 (81.8) 
 
553 (20.5) 
2149 (79.5) 
 
2.287 
 
 
 
 
0.13 
Procedure type:  
   Primary PCIa n (%) 
 
32 (3.4) 
 
52 (1.9) 
 
11.069 
 
2.7 
 
0.011 
   Elective PCIa n (%) 69 (7.4) 186 (6.9)  0.6  
   Ad hoc PCIa n (%) 108 (11.6) 263 (9.7)  1.7  
   Diagnostic angiography n (%) 720 (77.5) 2205 (81.5)  -2.6  
Route:        
   Femoral n (%) 
 
855 (92.1) 
 
2190 (81.0) 
 
63.820 
 
7.9 
 
<0.001 
   Radial n (%) 70 (7.5) 503 (18.6)  -8.0  
   Brachial n (%) 3 (0.3) 10 (0.4)  -0.2  
Arterial puncture side:  
   Right n (%) 
 
829 (93.8) 
 
2497 (95.5) 
 
4.107 
  
0.043 
   Left n (%) 55 (6.2) 118 (4.5)    
Sheath size:      
   5Fb n (%) 
 
250 (26.9) 
 
838 (31.0) 
 
5.697 
 
-2.3 
 
0.06 
   6Fb n (%) 673 (72.4) 1845 (68.3)  2.4  
   ≥ 7Fb n (%) 6 (0.6) 20 (0.7)  -0.3  
Multiple punctures (i.e. > 1) n (%) 129 (14.7) 251 (9.7) 16.502  <0.001 
Total heparin dose mean (SD) 2854.3 
(2090.2) 
2674.6 
(1971.0) 
  0.022 
Abciximab n (%) 20 (2.2) 26 (1.0) 7.827  0.005 
AR = adjusted residual: presented for variables with more than 2 categories 
(%) = valid % presented for each variable 
a PCI = percutaneous coronary intervention 
b F = French 
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Post-procedure variables significantly associated with bruising are presented in Table 26. 
There was a higher incidence of bruising in patients with a blood pressure ≥ 140mmHg pre 
sheath removal, but a lower incidence associated with experienced CAU nurses removing 
arterial sheaths. 
 
Table 26 Comparison of patients with and without bruising according to post-
procedure variables 
Variable Cases with 
bruising 
(N=931) 
Cases 
without 
bruising 
(N=2707) 
χ2 AR P value 
Post-procedure  
Sheath dwell time minutes: mean 
(SD) 
54.2 (70.2) 51.0 (68.2)   0.22 
SBPa pre sheath removal:   
   ≥ 140mmHg n (%) 
 
440 (47.5) 
 
1070 (39.6) 
 
17.648 
  
<0.001 
   < 140mmHg n (%) 486 (52.3) 1630 (60.4)    
Sheath remover: 
   Cardiologist n (%) 
 
122 (13.2) 
 
311 (11.6) 
 
21.203 
 
1.3 
 
<0.001 
   Advanced Trainee n (%) 102 (11.0) 243 (9.1)  1.8  
   CAUb experienced RNc n (%) 370 (40.0) 1308 (48.7)  -4.6  
   All other nurses n (%) 331 (35.8) 823 (30.7)  2.9  
Femoral haemostasis:  
   Manual n (%) 
 
370 (43.3) 
 
975 (44.6) 
 
0.620 
 
-0.7 
 
0.89 
   FemostopTM n (%) 269 (31.5) 684 (31.3)  0.1  
   Vascular closure devices n (%) 200 (23.4) 486 (22.3)  0.7  
   Other n (%) 15 (1.8) 39 (1.8)  -0.1  
AR = adjusted residual: presented for variables with more than 2 categories 
(%) = valid % presented for each variable 
a SBP = systolic blood pressure 
b CAU = Cardiac Angiography Unit 
c RN = registered nurse 
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Using backward conditional logistic regression techniques, nine variables significantly 
contributed to bruising accounting for 9.5% of shared variance (R2=0.095).  
 
Females were almost 1.4 times more likely to experience bruising complications compared 
to males. Patients with diabetes or having a previous angiography/PCI procedure were less 
likely to experience bruising. Over time from 2007 to 2012, the risk of bruising decreased by 
nearly 50% (Table 27). 
 
Of the procedural and post-procedure variables entered into the model, five variables were 
independently associated with risk of bruising (Table 27). Patients undergoing Primary PCIs 
were twice as likely to experience bruising compared to diagnostic angiography alone. 
Patients with left sided arterial access rather than the more commonly performed right sided 
access, those with multiple arterial punctures and also patients with a pre-sheath removal 
systolic blood pressure of ≥ 140mmHg were associated with a higher risk of bruising. 
Conversely, patients where access was via the radial artery were less likely to experience 
bruising than patients having femoral access procedures.  
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Table 27 Multivariate predictors of bruising complications 
Predictor variable B (S.E.) P value Odds ratio 
(Confidence interval 
95%) 
Gender  - female 0.321 (0.087) <0.001 1.379 (1.164-1.634) 
History of diabetes - Yes -0.510 (0.108) <0.001 0.600 (0.485-0.743) 
History of previous 
angiography/PCIa - Yes 
-0.355 (0.093) <0.001 0.701 (0.585-0.841) 
Year of procedure – 
   2008 vs 2007 
   2009 vs 2007 
   2010 vs 2007 
   2011 vs 2007 
   2012 vs 2007 
 
0.048 (0.204) 
-0.019 (0.200) 
-0.141 (0.212) 
-0.358 (0.216) 
-0.672 (0.229) 
 
0.813 
0.925 
0.505 
0.097 
0.003 
 
1.049 (0.703-1.567) 
0.981 (0.662-1.453) 
0.868 (0.573-1.316) 
0.699 (0.458-1.067) 
0.511 (0.326-0.800) 
Procedure –  
   Ad hoc PCIa vs angiography 
   Elective PCIa vs angiography 
   Primary PCIa vs angiography 
 
0.269 (0.139) 
0.338 (0.174) 
0.807 (0.249) 
 
0.054 
0.052 
0.001 
 
1.309 (0.996-1.720) 
1.402 (0.997-1.973) 
2.241 (1.375-3.653) 
Route of arterial access –  
   Radial vs femoral 
   Brachial vs femoral 
 
-0.784 (0.150) 
-0.726 (1.809) 
 
<0.001 
0.369 
 
0.457 (0.340-0.612) 
0.484 (0.099-2.362) 
Arterial access side  - left 0.404 (0.194) 0.037 1.498 (1.024-2.191) 
Multiple punctures (> 1) 0.567 (0.128) <0.001 1.762 (1.372-2.264) 
SBPb ≥ 140mmHg 0.381 (0.086) <0.001 1.464 (1.237-1.732) 
a PCI = percutaneous coronary intervention 
b SBP = systolic blood pressure 
 
 
4.7 Factors associated with rare complications 
There was a higher incidence of rare complications in females compared to males (Table 
28). 
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Table 28 Comparison of patients with and without rare complications according to 
clinical history 
Variable Cases with rare 
complications 
(N=31) 
Cases without 
rare 
complications 
(N=3762) 
χ2 P value 
Clinical history 
Age mean (SD) 64.8 (14.6) 65.9 (12.12)  0.62 
BMIa mean (SD) 28.4 (5.7) 29.5 (6.0)  0.30 
Sex:   female n (%) 19 (61.3) 1366 (36.3) 8.276 0.004 
          male n (%) 12 (38.7) 2396 (63.7)   
Hypertension n (%) 23 (74.2) 2709 (72.0) 0.073 0.79 
Peripheral vascular disease n (%) 6 (19.4) 638 (17.0) 0.125 0.72 
Diabetes n (%) 5 (16.1) 937 (24.9) 1.269 0.26 
Previous angiography/PCIb n (%) 10 (32.3) 1666 (44.3) 1.803 0.18 
Chronic renal impairment n (%) 6 (19.4) 515 (13.7) 0.833 0.36 
Ischaemic heart disease n (%) 12 (38.7) 1748 (46.5) 0.743 0.39 
a BMI = body mass index 
(%) = valid % presented for each variable 
b PCI = percutaneous coronary intervention 
 
Pre-procedure medications were not associated with an increase in rare complications 
(Table 29). 
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Table 29 Comparison of patients with and without rare complications according to 
pre-procedure medication history 
(%) = valid % presented for each variable 
a IV = intravenous 
b UFH = unfractionated heparin 
c s/c = subcutaneous 
d LMWH = low molecular weight heparin 
 
There was no statistically significant difference in the occurrence of rare complications 
comparing either the procedure years during the study period, and when comparing 
inpatients versus outpatients (Table 30). 
Variable Cases with 
rare 
complications 
(N=31) 
Cases without 
rare  
complications 
(N=3762) 
χ2 P value 
Pre-procedure medications 
Aspirin n (%) 28 (90.3) 3072 (81.8) 1.501 0.22 
Clopidogrel n (%) 21 (67.7) 2094 (55.8) 1.780 0.18 
Warfarin n (%) 3 (10.0) 255 (6.8) 0.480 0.49 
Warfarin days stopped pre 
procedure : mean (SD) 
3.3 (2.1) 5.5 (3.9)  0.33 
Antihypertensives n (%) 22 (71.0) 2833 (75.5) 0.342 0.56 
Thrombolysis n (%) 2 (6.7) 107 (2.9) 1.540 0.22 
IVa UFHb n (%) 3 (10.0) 304 (8.1) 0.140 0.71 
IVa Heparin to sheath insertion 
time in minutes:  mean (SD) 
42.0 (41.9) 352.5 (1356.4)  0.69 
s/cc LMWHd/UFHb n (%) 9 (30.0) 999 (26.6) 0.171 0.68 
s/cc LMWHd/UFHb last dose  to 
sheath out in days: mean (SD)  
1.00 (0.5) 1.54 (1.7)  0.38 
Tirofiban n (%) 0 (0.0) 15 (0.4) 0.123 0.73 
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Table 30 Comparison of patients with and without rare complications according to 
year of procedure and admission status 
Variable Cases with 
rare 
complications 
(N=31) 
Cases without 
rare 
complications 
(N=3762) 
χ2 AR P value 
Year of procedure:        
   2007 n (%) 
   2008 n (%) 
 
1 (3.2) 
12 (38.7) 
 
275 (7.3) 
851 (22.6) 
 
8.687 
 
-0.9 
2.1 
 
0.12 
   2009 n (%) 10 (32.3) 864 (23.0)  1.2  
   2010 n (%) 3 (9.7) 580 (15.4)  -0.9  
   2011 n (%) 2 (6.5) 684 (18.2)  -1.7  
   2012 n (%) 3 (9.7) 508 (13.5)  -0.6  
Patient status:    
   Inpatient n (%) 
 
20 (64.5) 
 
1799 (47.8) 
 
3.434 
  
0.06 
   Outpatient n (%) 11 (35.5) 1963 (52.2)    
AR = adjusted residual: presented for variables with more than 2 categories  
(%) = valid % presented for each variable 
 
 
Intra-procedural factors associated with rare complications are presented in Table 31. 
Femoral and brachial access was associated with a higher incidence of rare complications 
compared to radial access where there were no rare complications.  
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Table 31 Comparison of patients with and without rare complications according to 
intra-procedure variables 
Variable Cases with 
rare 
complications 
(N=31) 
Cases without 
rare 
complications 
(N=3762) 
χ2 AR P 
value 
Intra-procedure 
Sheath inserter:   
   Cardiologist n (%) 
   Advanced Trainee n (%) 
 
3 (9.7) 
28 (90.3) 
 
755 (20.1) 
3001 (79.9) 
 
2.087 
 
 
 
0.15 
Procedure type:   
   Primary PCIa n (%) 
 
3 (0.0) 
 
87 (2.3) 
 
1.490 
 
-0.9 
 
0.69 
   Elective PCIa n (%) 3 (9.7) 261 (6.9)  0.6  
   Ad hoc PCIa n (%) 2 (6.5) 379 (10.1)  -0.7  
   Diagnostic angiography n (%) 26 (83.9) 3032 (80.7)  0.5  
Route:        
   Femoral n (%) 
 
30 (96.8) 
 
3147 (83.8) 
 
12.423 
 
2.0 
 
0.002 
   Radial n (%) 0 (0.0) 595 (15.8)  -2.4  
   Brachial n (%) 1 (3.2) 13 (0.3)  2.6  
Arterial puncture side: 
   Right n (%) 
 
27 (93.1) 
 
3445 (95.1) 
 
0.257 
  
0.61 
   Left n (%) 2 (6.9) 176 (4.9)    
Sheath size:      
   5Fb n (%) 
 
13 (41.9) 
 
1127 (30.0) 
 
2.229 
 
1.4 
 
0.33 
   6Fb n (%) 18 (58.1) 2603 (69.3)  -1.3  
   ≥ 7Fb n (%) 0 (0.0) 26 (0.7)  -0.5  
Multiple punctures (i.e. > 1)  
n (%) 
3 (9.7) 388 (10.9) 0.045  0.83 
Total heparin dose mean (SD)  2532.3 
(1995.6) 
2715.7 
(1998.3) 
  0.61 
Abciximab n (%) 1 (3.3) 45 (1.2) 1.098  0.30 
AR = adjusted residual: presented for variables with more than 2 categories 
(%) = valid % presented for each variable 
a PCI = percutaneous coronary intervention 
b F = French 
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Patients with a systolic blood pressure of ≥ 140mmHg pre sheath removal were significantly 
associated with more rare complications compared to patients with a SBP of < 140mmHg 
(Table 32).  
 
Table 32 Comparison of patients with and without rare complications according to 
post-procedure variables 
Variable Cases with 
rare 
complications 
(N=31) 
Cases without 
complications 
(N=3762) 
χ2 AR P 
value 
Post procedure  
Sheath dwell time minutes: 
mean (SD) 
38.4 (43.1) 51.7 (68.3)   0.29 
SBPa pre sheath removal:  
   ≥ 140mmHg n (%) 
 
19 (61.3) 
 
1545 (41.2) 
 
5.110 
  
0.024 
   < 140mmHg n (%) 12 (38.7) 2204 (58.8)    
Sheath remover: 
   Cardiologist n (%) 
 
5 (16.1) 
 
446 (12.0) 
 
4.499 
 
0.7 
 
0.21 
   Advanced Trainee n (%) 6 (19.4) 349 (9.4)  1.9  
   CAUb experienced RNc n (%) 12 (38.7) 1742 (46.7)  -0.9  
   All other nurses n (%) 8 (25.8) 1195 (32.0)  -0.7  
Femoral haemostasis: 
   Digital n (%) 
 
11 (36.7) 
 
1391 (44.3) 
 
4.000 
 
-0.8 
 
0.26 
   FemostopTM n (%) 8 (26.7) 982 (31.3)  -0.5  
   Vascular closure device n (%) 11 (36.7) 698 (22.2)  1.9  
   Other n (%) 0 (0.0) 67 (2.1)  -0.8  
Total digital pressure (minutes): 
Mean (SD) 
14.7 (17.8) 8.5 (10.6)   0.07d 
AR = adjusted residual: presented for variables with more than 2 categories 
a SBP = systolic blood pressure 
(%) = valid % presented for each variable 
b CAU = Cardiac Angiography Unit 
c RN = Registered nurse 
d equal variances not assumed 
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Using backward conditional logistic regression techniques, only one variable was 
independently associated with the risk of rare complications (Table 33). Females were more 
than two and a half times more likely to experience rare complications compared to males. 
 
Univariate variables entered into the model accounted for 7.1 % of shared variance with rare 
peripheral vascular access site complications (R2=0.071). 
 
Table 33 Multivariate predictors of rare complications 
Predictor variable B (S.E.) P value Odds ratio 
(Confidence interval 
95%) 
Sex  - female 0.981 (0.372) 0.008 2.667 (1.287-5.530) 
Route of arterial access: 
   Radial vs femoral 
   Brachial vs femoral 
 
-16.432 (1609.670) 
2.087 (1.067) 
 
0.992 
0.051 
 
0.000b (0.000) 
8.057c (0.995-65.248) 
SBPa ≥ 140mmHg 0.714 (0.372) 0.055 2.043 (0.986-4.234) 
a SBP = systolic blood pressure 
b no participants in radial access group with rare complication  
c only 1 participant in brachial access group with rare complication 
 
4.8 Summary of multivariate associations between variables significantly contributing 
to complications 
Variables which contributed to the development of bruising, haematoma, bleeding and rare 
complications involved demographic, clinical, procedural and post-procedural factors.  Of the 
demographic and clinical factors, female sex was independently associated with 
complications, contributing to bruising, haematomas and the occurrence of rare 
complications (Table 34). Diabetes and a history of previous angiography/PCI were 
negatively associated with bruising and haematomas. Taking aspirin and administration of 
tirofiban was associated with haematoma formation, but not other complications. 
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Of the intra-procedure variables, patients experiencing procedures in 2012 had less risk of 
developing bruising compared to 2007 (Table 34).  Procedures involving PCI contributed to 
bruising or bleeding complications, with Primary PCI more than doubling a patient’s risk of 
bruising, and patients having ad hoc PCI or elective PCI alone being three and a half times 
more likely to develop bleeding complications than non-PCI patients. Patients having femoral 
access procedures compared to radial access, or arterial access via the left side were more 
likely to have bruising complications. Multiple arterial punctures independently contributed to 
both bruising and haematomas. Of the post-procedure variables, systolic blood pressure ≥ 
140mmHg was independently associated with bruising and haematomas.
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Table 34 Summary table of variables contributing to complications by multivariate 
analysis 
 Haematoma Bleeding Bruising Rare 
complications 
 ↑ or ↓ in risk ↑ or ↓ in risk ↑ or ↓ in risk ↑ or ↓ in risk 
Clinical history 
Gender – female ↑  ↑ ↑ 
History of hypertension  ↑   
Diabetes ↓  ↓  
History of previous angio/PCI ↓  ↓  
Medications 
Aspirin ↑    
Tirofiban ↑    
Peri-procedure 
Year of procedure –  
  2012 vs 2007 
  2009,2010,2011 vs 2007 
 
 
 
 
 
↓ 
 
↓ 
 
 
Procedure – 
  Primary PCI vs angiography 
  Ad hoc PCI vs angio 
  Elective PCI vs angio 
  
 
↑ 
↑ 
 
↑ 
 
 
 
Route – radial vs femoral ↓ ↑ ↓  
Side of access – left vs right   ↑  
Multiple punctures (> 1) ↑  ↑  
Post-procedure 
Systolic BP ≥ 140mmHg ↑  ↑  
Longer sheath dwell time  ↑   
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4.9 Summary of results 
This study investigated the various peripheral vascular access site complications following 
coronary angiography and PCI. The patient population was predominantly male, had a 
history of hypertension and a high proportion were taking antiplatelet and antihypertensive 
medications. Analysis of procedural variables revealed the most common procedure was 
coronary angiography, performed via the right femoral arterial approach, with 6 French 
sheaths inserted by Advanced Trainees in the majority of procedures. Use of the radial 
artery approach has increased from 2010 onwards and the majority of sheaths were 
removed by registered nurses.  
 
Analysis of peripheral vascular access site complications revealed almost half the patients 
experienced a vascular access site complication following their procedure. Bruising was the 
most common complication (44.6%), followed by haematoma (15.5%) and bleeding (9.5%). 
Rare complications included retroperitoneal bleeding, pseudoaneurysms, complications 
resulting in vascular surgery, access site infection (when combined accounting for 1.02% of 
complications) and there were no AV fistulas. 
 
Assessment of demographic factors revealed women were independently associated with 
haematoma, bruising and rare complications. Older age was not associated with 
complications. Of the clinical history variables, a history of hypertension was associated with 
bleeding and both diabetes and a history of previous coronary angiography or PCI were 
associated with fewer haematoma and bruising complications. A history of PVD, chronic 
renal impairment or ischaemic heart disease was not associated with the occurrence of 
complications. Both aspirin and tirofiban were associated with development of haematomas 
but no other complications. The relationship of aspirin and tirofiban with haematomas but not 
other complications such as bleeding is likely very complex and multifactorial. Other 
medications did not contribute to the risk of complications in the study reported here. 
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Analysis of procedural factors revealed several important associations with various 
peripheral vascular access site complications. PCI procedures were associated with 
bleeding and bruising, left sided arterial access was associated with bruising, and multiple 
arterial punctures were associated with both haematoma and bruising. Procedures 
performed in the later study years were associated with less bleeding and bruising 
complications compared to the first year of the study period (2007). Radial arterial access 
was associated with fewer haematoma, bleeding and bruising complications compared to 
femoral arterial access. Size of arterial sheath or whether the arterial sheath was inserted by 
a Cardiologist or Cardiac Advanced Trainee were not associated with peripheral vascular 
access site complications. 
 
Of the post-procedure factors associated with vascular complications, pre-sheath removal 
SBP ≥ 140mmHg was associated with haematomas and bruising and longer sheath-dwell 
time was associated with bleeding complications. Other post-procedure factors such as level 
of experience of person removing sheath or whether sheaths were removed by doctors or 
nurses were not associated with complications. Finally, femoral haemostasis method was 
not associated with vascular complications. 
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Chapter 5 – DISCUSSION 
 
5.1 Introduction 
In this retrospective study, peripheral vascular access site complications associated with 
coronary angiography and PCI were identified. A secondary aim of the study was to identify 
demographic, clinical, procedural and post-procedural factors associated with complications. 
The major findings of this study are: 1) peripheral vascular access site complications 
associated with coronary angiography and PCI from most to least frequent are bruising, 
haematoma and bleeding, followed by rare complications (inclusive of pseudoaneurysm, 
retroperitoneal bleeding, complications resulting in vascular surgery, puncture site infection 
and AV fistula); 2) female gender is independently associated with risk of complications such 
as bruising, haematoma and rare complications; 3) a history of hypertension is associated 
with higher risk of bleeding complications, whereas  diabetes and a previous angiography or 
PCI are associated with lower risk of bruising and haematoma complications; 4) the 
antiplatelet medications aspirin and tirofiban are associated with higher risk of haematomas; 
5) procedural variables; left-sided access, PCI and multiple punctures are associated with 
higher risk of bruising, haematoma and bleeding, whereas radial arterial access and later 
procedural years are independently associated with lower risk; and 6) post procedure 
variables; SBP ≥ 140mmHg pre sheath removal and a longer sheath dwell time are 
significantly associated with higher risk of developing bruising, haematoma and  bleeding. 
 
5.2 Haematoma 
Haematomas occurred in 15.5% of patients following coronary angiography or PCI, although 
the majority of these were small in size. Moderate or large haematomas occurred in 6% of 
patients which is consistent with previous research suggesting infrequent occurrence of 
significant haematomas (Kinnaird et al., 2003; Sulzbach-Hoke et al., 2010; Tewari et al., 
2013). Of all peripheral vascular access site complications, haematomas are the most 
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commonly reported in the literature although classifications utilised to define haematomas 
have been vastly different among studies. Nurse-led studies are more likely to define 
haematomas purely based on size rather than the implications such as a requirement for 
monitoring of blood count, administration of blood products or vascular specialist input. The 
study reported here collected all-sized haematomas with those ≥ 5cm included for analysis. 
The incidence of haematomas was consistent with that reported in other studies (Chlan et 
al., 2005; McCabe et al., 2001; Sulzbach-Hoke et al., 2010; Woodhead et al., 2007). 
 
Females were at an increased risk of developing haematomas compared to males. This is 
consistent with a meta-analysis of 137,150 patients from 12 studies where among patients 
undergoing PCI, females were 1.4 – 4 times more likely to develop vascular complications 
including haematomas, than males (Lansky et al., 2005). 
 
It has been proposed that the reduced risk of haematoma for women in more recent studies 
has been attributed to less aggressive anticoagulation regimens, increased use of weight-
adjusted heparin dosing, introduction of smaller sheaths and early sheath removal (Lansky 
et al., 2005). The increased risk of haematoma for women may also be associated with the 
smaller vascular lumens for both the femoral and radial artery in females compared to 
males. There may be other factors unique to females that contribute to the increased risk 
that are not measured in this study.  
 
Risk scores have previously been developed to predict bleeding, but not haematoma risk in 
women (Mehran et al., 2010). In Australia and New Zealand, recent practice guidelines 
developed by Rolley et al. (2011) noted females were at an increased risk of complications 
and the guidelines raised an awareness of female gender as a risk for access site 
complications. Further studies are required to determine if a reduction in haematoma risk to 
females compared to males can be achieved. 
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Patients taking aspirin were at an increased risk of developing haematomas following 
coronary angiography or PCI in this study. Studies have shown mixed results on whether 
aspirin is associated with bleeding complications such as haematoma after coronary 
angiography and PCI, with aspirin resulting in an increased risk in some (Muller et al., 1992; 
Yatskar et al., 2007) and others showing no association (McCabe et al., 2001; Sabo et al., 
2008; Warren et al., 1999). Study design and higher dose of aspirin may have contributed to 
the variation in reported risk. Of the two studies that report a higher risk of haematoma with 
aspirin, Muller et al. (1992) included higher doses of aspirin (325mg/day) than that used in 
contemporary practice, while Yatskar et al. (2007) included the higher risk PCI patient 
population and outcomes involving only the most severe haematomas requiring blood 
transfusion. For studies reporting no association between aspirin and haematomas, this may 
have been due to small samples sizes identified by several authors, a high percentage of 
patients taking aspirin (≥ 95%) and a large number of exclusion criteria for complex patients 
who may be at higher risk of haematoma complications. 
 
Recent PCI-related research reports close to 100% of patients taking aspirin (Sabo et al., 
2008; Sulzbach-Hoke et al., 2010), making assessment of aspirin’s contribution to 
haematomas difficult. Similarly, findings from angiography-only studies should be applied to 
PCI patient populations with caution. Several studies involving both angiography and PCI, 
have not shown an association between aspirin and haematomas, however as these have 
been studies with small samples sizes, the true effect of aspirin could not be verified (Berry 
et al., 2004; Warren et al., 1999). The findings in the study reported here are unique in 
showing an association between aspirin and risk of haematoma in patients following 
coronary angiography and PCI. 
 
The mechanism of aspirin in relation to haemostasis is platelet inhibition which is irreversible 
for the lifetime of the platelet, approximately 10 days, (Awtry & Loscalzo, 2000). Aspirin has 
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been shown to prolong bleeding time by more than 10 minutes in up to 25% of participants in 
a small study of 48 healthy volunteers (Sonksen, Kong, & Holder, 1999).  Antiplatelet 
medications such as aspirin have been associated with other types of haematomas such as 
spontaneous spinal epidural and perirenal haematomas (Moon et al., 2009; Yamamoto & 
Yasunaga, 2005) suggesting aspirin plays an important role in the progression of 
haematoma. While patients taking aspirin are at an increased risk of bleeding and 
subsequent haematomas, stopping aspirin pre-procedurally may place the patient at an 
increased risk of cardiovascular events making it less likely that stopping aspirin would be 
preferable, despite the increased risk of haematoma post procedure. 
 
Tirofiban, a glycoprotein (GP) IIb/IIIa inhibitor was associated with higher risk of 
haematomas in this study. While these results should be interpreted with caution due to the 
limited number of haematoma events (3 patients) in this study subset of only 15 patients 
receiving tirofiban, the increased risk of peripheral vascular complications including 
haematomas with GP IIb/IIIa inhibitors has been reported previously (Doyle et al., 2008; Feit 
et al., 2007). 
 
Intravenous GP IIb/IIIa receptor blocking agents such as tirofiban have been identified as 
having potent antithrombotic properties leading to significant improvements in PCI procedure 
success with reduced abrupt vessel closure, thrombus formation and peri-procedural 
myocardial infarction (Kern et al., 2007, p. 182). As newer more potent oral antiplatelet 
regimens (i.e. high dose clopidogrel 600mg loading) or newer agents (e.g. prasugrel and 
ticagrelor) become more widely adopted, the advantages seen previously with GP IIb/IIIa 
inhibitors are less apparent (Eeckhout et al., 2012b, p. 831). Current European Society of 
Cardiology guidelines report GP IIb/IIIa inhibitor use as reasonable practice only in the event 
of angiographic evidence of large thrombus, slow- or no-reflow and other thrombotic 
complications (Windecker et al., 2015). Hence GP IIb/IIIa inhibitor administration will likely 
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decrease unless future studies show significant clinical benefit without additional major 
adverse cardiac and cerebrovascular events or access site bleeding complications. 
 
Patients requiring more than one arterial puncture were at a significantly higher risk of 
developing haematoma complications than those receiving a single arterial puncture. This 
finding is consistent with 2 other studies reporting an increased risk of haematoma with both 
coronary angiography and PCI (Andersen et al., 2005; Berry et al., 2004). The study by 
Anderson et al. (2005) of 474 patients identified 9 factors contributing to an increased risk of 
haematomas, of which multiple arterial punctures was the strongest independent predictor 
with patients having 3.4 times the risk of haematomas. Similarly, multiple punctures were the 
strongest predictor of haematomas following coronary angiography and PCI in a study of 
309 participants (Berry et al., 2004). 
 
Some larger studies have not included multiple punctures as a potential factor in the 
development of haematomas. For example, in three studies reporting complications for 
vascular closure devices, patients who had difficult arterial access or multiple punctures 
have been excluded, suggesting an awareness of increased risk in these patients (Chevalier 
et al., 2003; Eggebrecht et al., 2004; Warren et al., 1999).  
 
The increased risk for the development of haematomas with multiple arterial punctures may 
be due to extra luminal bleeding during difficult arterial access or inadequate manual 
compression between access attempts, causing a collection of blood under the skin. While 
Anderson et al. (2005) outline the importance of experienced operators to reduce the risk of 
multiple punctures and subsequent complications, interestingly, the level of experience was 
not associated with an increased risk of haematoma complication in the study reported here. 
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A systolic blood pressure ≥ 140mmHg prior to a patient’s arterial sheath removal was 
independently associated with risk of haematomas. This finding is consistent with other 
studies reporting a higher blood pressure associated with the development of haematomas 
(Andersen et al., 2005; Liew et al., 2007; Nordrehaug et al., 1996). The increased risk of 
high blood pressure in the development of complications such as haematoma is 
acknowledged in several studies where participants received pre-treatment with vasoactive 
medications (for example, nitrogylcerin or nifedipine) to reduce the SBP to < 140mmHg  
(Boztosun et al., 2008; Jaspers & Benit, 2003; Warren et al., 1999). Other studies have 
excluded patients with pre-procedure severe hypertension (eg SBP > 190mmHg) (Cheng et 
al., 2013; Kussmaul 3rd et al., 1996) presumably due to the potential risk of complications.  
 
Patients with a SBP ≥ 140mmHg may not only be at an increased risk of developing 
haematomas, but they may also be treated differently than normotensive patients during 
their recovery period. In a study of 1650 patients undergoing coronary angiography 
(Boztosun et al., 2008), patients were either ambulated early (2 hours post haemostasis) or 
as per standard practice (4 to 5 hours post haemostasis) and the two mobilisation groups 
were compared for risk of complications such as haematoma. Patients with a high blood 
pressure (BP > 180/100mmHg) were more likely not to be ambulated early, and were more 
likely to require longer haemostasis times. This suggests nurses and doctors have an 
awareness of the increased risk of high blood pressure pre sheath removal. In an attempt to 
reduce the development of complications such as haematoma, nurses may adjust their 
practices to include prolonged haemostasis techniques and increased periods of bedrest in 
patients with a high SBP.  
 
Although uncontrolled blood pressure is considered a relative contraindication for coronary 
angiography and PCI (Kern, 2011, p. 4), increased risk for patients with hypertension 
requires clinical consideration when it occurs. Altering arterial access route choice or method 
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of haemostasis, or delaying sheath removal until blood pressure is controlled are techniques 
that may be employed to prevent complications. More attention may be required to actively 
lower hypertensive patients’ blood pressure during the haemostasis period to reduce 
potential prolonged haemostasis, and ultimately to reduce a patients risk of development of 
haematomas. 
 
Diabetic patients were at a lower risk of developing haematomas than non-diabetics in this 
study. This finding has only been reported in one prior study by Andersen et al. (2005), with 
a 70% less risk of developing haematomas in patients with diabetes undergoing coronary 
angiography and PCI. A proposed explanation for the reduced risk of haematoma in patients 
with diabetes may be related to the disease process, with a number of mechanisms 
underlying cardiovascular disease in diabetes resulting in a prothrombotic state. This 
prothrombotic state is characterised by increased fibrinogen levels, increased plasminogen 
activator inhibitor-1 and abnormalities in platelet function. Platelet dysfunction is thought to 
increase the likelihood of atherosclerosis as a result of platelet activity where damage to the 
integrity of the vessel wall may occur (Vinik, Erbas, Park, Nolan, & Pittenger, 2001). This 
increased platelet activity in diabetics at vessel injury sites, such as arteriotomy sites during 
coronary angiography and PCI, may result in an increased ability to form a clot at the vessel 
wall during haemostasis and hence reduce bleeding complications. 
 
Patients who had a previous angiogram or PCI had a lower risk of developing haematoma 
complications. This finding has not been reported elsewhere in the literature. However, 
previous PCI was associated with a lower risk of vascular access site complications 
including haematomas in several studies, with up to 41% lower risk reported (Ahmed et al., 
2009; Feit et al., 2007; Sanborn et al., 2010; Tavris et al., 2005). It is unclear in these studies 
if arterial access was performed at the same site, different side or different route altogether 
or whether the previous PCI was performed recently or many years before. These unknown 
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factors may impact a patient’s risk of developing a peripheral vascular complication and 
hence further research is warranted to identify exact determinants of risk in these patients 
who have had previous procedures. While the mechanism for fewer haematomas in patients 
having previous angiography or PCI is unknown, it is possible that patients gain experience 
from past procedures on access site self-care.  
 
Radial artery access was associated with a significantly lower risk of haematomas when 
compared to femoral access. This finding is consistent with the largest known randomised 
controlled trial that compared femoral and radial vascular access among 7021 patients, with 
a 40% less risk of developing large haematomas following radial access (Jolly et al., 2011). 
The lower risk associated with radial arterial access compared to femoral access was also 
confirmed by Tewari et al. (2013). 
 
The reduced risk of haematomas with radial access procedures may be related to several 
factors: firstly, closer proximity of the radial artery to skin surface and potentially easier 
arterial puncture and haemostasis; secondly, less subcutaneous space for haematomas to 
collect; and finally, visual inspection and control of the radial site is easier than in femoral 
sites (Agostoni et al., 2004; Dauerman, Rao, Resnic, & Applegate, 2011). 
 
In summary, eight variables were independently associated with haematomas accounting for 
8% of the variance, suggesting there are other unmeasured factors associated with risk of 
haematomas to be determined in future research. 
 
5.3 Bleeding 
Bleeding occurred in 9.5% of patients following coronary angiography or PCI, although the 
majority were small (defined as venous tracking ooze or bleeding caught early and 
prevented from becoming large). Moderate or large bleeding (defined as arterial bleeding, 
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contained or uncontrolled) occurred in only 3.4% of patients, which is consistent with 
previous studies suggesting bleeding occurs infrequently (Buchler et al., 2008; 
Chandrasekar et al., 2001; Dangas et al., 2001; Duffin et al., 2001; Omoigui et al., 1995). Of 
all the studies reporting peripheral vascular access site complications, bleeding was the third 
most commonly reported complication after haematomas and pseudoaneurysms although 
classifications utilised to define bleeding have been vastly different among studies. Nurse-
led studies tend to define bleeding purely based on bleeding that was visible (Chlan et al., 
2005; Higgins et al., 2008; Walker, Jen, McCosker, & Cleary, 2008), rather than identification 
by blood count derangement, administration of blood products or vascular specialist input 
(Jolly et al., 2011; Ramana et al., 2008; Sanborn et al., 2010). The study reported here 
collected all-sized bleeding with those moderate to large events included for analysis with 
the incidence of bleeding (3.4%) consistent with these studies (Chlan et al., 2005; Dumont, 
Keeling, Bourguignon, Sarembock, & Turner, 2006; Higgins et al., 2008; McCabe et al., 
2001; Sulzbach-Hoke et al., 2010). 
 
A history of hypertension was independently associated with an increased risk of vascular 
access site bleeding. This finding is consistent with others reporting a history of hypertension 
associated with the development of bleeding (Yatskar et al., 2007). The increased risk of 
chronic hypertension in developing bleeding complications has been postulated by previous 
authors as being related to vessel wall changes including vascular hypertrophy, increased 
arterial stiffness and increased pressure loading (Moscucci et al., 1994; Perings, Kelm, Jax, 
& Strauer, 2003). However, the exact mechanisms remain unclear. In a large retrospective, 
correlation study of 11,119 patients who underwent coronary angiography and/or PCI, 
predictors for vascular complications including bleeding from the access site were 
investigated (Dumont et al., 2006). While a history of hypertension was associated with 
development of vascular complications, this association was accounted for by other 
demographic and procedural factors in the final multiple regression model. The same 
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investigator in a smaller, case-matched controlled study of 300 patients reported a history of 
chronic hypertension was independently associated with 60% less risk, although a mean 
SBP of ≥ 160mmHg during the procedure was associated with an 8 times higher risk of 
complications (Dumont, 2007). It was hypothesised medications such as angiotensin-
converting enzyme inhibitors and beta-blockers used in patients with chronic hypertension 
may be changing the integrity of the vessel wall and providing protective effects against 
vascular access site complications (Dumont, 2007). 
 
While a history of hypertension was associated with bleeding, it was not associated with 
bruising and haematomas. Conversely, a high blood pressure pre sheath removal (SBP ≥ 
140mmHg) contributed to bruising and haematomas but not bleeding complications. In the 
study reported here, patients with a history of hypertension were also more likely to be 
hypertensive pre sheath removal. Further studies are required to evaluate the association 
between chronic hypertension, high SBP pre sheath removal and whether active measures 
to reduce a patient’s blood pressure pre sheath removal will reduce peripheral vascular 
bleeding. 
 
Patients undergoing ad hoc PCI and elective PCI were significantly more likely to have 
bleeding complications compared to diagnostic angiography alone. However, not all PCI 
procedures lead to more bleeding as Primary PCI (i.e. emergency PCI) was not associated 
with bleeding. There may be several casual factors such as the increased use of vascular 
closure devices in Primary PCI procedures. Bleeding complications occurred in only 3 out of 
84 patients having a Primary PCI and these numbers are too small to form the basis for 
conclusions. 
 
PCI procedures were most commonly performed via the femoral route (77.8%), with 
haemostasis achieved using different methods depending on the type of PCI procedure. 
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Haemostasis was achieved by vascular closure device (VCD) deployment in elective PCI 
(47.0%), ad hoc PCI (59.7%) and in Primary PCI (74.3%). This may suggest a possible bias 
towards VCD use in procedures perceived as higher in risk for development of bleeding 
complications, such as Primary PCI. There may be an assumption amongst staff that the use 
of VCDs protects patients from bleeding complications in the setting of Primary PCI with 
patients possibly on higher antiplatelet and anticoagulation doses. 
 
The finding of increased peripheral access site bleeding following some, but not all types of 
PCI procedures has not been reported previously. Several studies described an increased 
risk of bleeding in PCIs compared to diagnostic angiography (Berry et al., 2004; Carere et 
al., 1998; Dumont et al., 2006; Tavris, Gallauresi, Dey, Brindis, & Mitchel, 2007; Tavris et al., 
2004), however the type of PCI (ad hoc, elective or emergency primary procedure) is not 
defined in these studies. Emergency indication for procedure may play some part in the 
increased risk of bleeding as found by Tavris et al. (2007), although the definition is unclear 
and may also include diagnostic angiography patients not requiring PCI. High routine 
anticoagulation regimens among PCI patients in the 1990s may have contributed to the risk 
of bleeding in studies of that era, although it is unlikely to have the same impact in the 
current era with lower anticoagulant doses (Kern, 2011, p. 372). It is uncertain whether the 
type of PCI really matters in terms of the risk of bleeding complications, as antiplatelets and 
anticoagulation are used in all types of PCIs. Finally, there may be other factors impacting 
on PCIs that were unmeasured in this study, hence further research may determine if all PCI 
procedure types are associated with an increased risk of bleeding, or whether some types 
are of less risk than others.  
 
Longer arterial sheath time was associated with increased risk of bleeding complications in 
the study reported here. Studies reporting sheath dwell time have shown mixed results with 
one documenting a significant association between long sheath dwell time and bleeding 
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complications (Feit et al., 2007), and others showing no significance (May et al., 2009; 
Pracyk et al., 1998). The REPLACE-2 Trial, a double-blind active-controlled trial of 6,001 
patients investigating various antithrombotic strategies for patients undergoing PCI, reported 
an association between prolonged sheath dwell time and major haemorrhage complications, 
with a sheath dwell time of > 6 hours associated with a greater risk of developing major 
haemorrhage (Feit et al., 2007). 
 
The increased risk of bleeding complications associated with long sheath dwell times may be 
due to several factors. Delays in sheath removal and hence prevention of haemostasis may 
result in bleeding from the effects of antiplatelet and anticoagulant medications, 
hypertension, difficult sheath insertion or artery trauma, patient discomfort related to 
prolonged supine positioning and hence compliance with instructions for prevention of 
complications. 
 
Procedure year was significantly associated with bleeding complications in this study with a 
50% reduction in bleeding complications between 2007 and 2012. This finding is consistent 
with other studies reporting downward temporal trends in bleeding complications (Ahmed et 
al., 2009; Applegate et al., 2008; Doyle et al., 2008). Practice changes over the years have 
been associated with this reduction in bleeding complications. Tavris et al (2007) describe a 
declining risk of bleeding for women over a 5 year period and proposed several practice 
changes including the use of smaller sheath sizes and post-procedure sheath management 
as reasons for the decline. However, while females were more likely to have smaller sheaths 
inserted than men in the current study (33.8% compared to 28%), interestingly sheath size 
was not independently associated with bleeding complications.  
 
High intra-procedural PCI heparin doses (≥ 10,000units) and the use of post-procedural IV 
heparin infusions used in the 1980s and early 1990s (Moscucci et al., 1994; Muller et al., 
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1992; Waksman et al., 1995) are considered outdated practice with intra-procedural weight-
based regimens of 40-70 units/kg of heparin now considered usual care (Kern, 2011, p. 
372). However, changes in heparin doses over time may not be the only factor for the 
changes in bleeding over time as dose of heparin administered was not independently 
associated with bleeding in the study reported here. 
 
The practice change most likely to have reduced the bleeding incidence over the course of 
this study period was the 40% increase in radial access procedures over the study time with 
a 90% lower risk of bleeding with radial access compared to femoral access on multivariate 
analysis. Moderate to large bleeding occurred in only 3.4% of all patients undergoing 
coronary angiography or PCI, and only two patients (0.05%) experienced moderate or large 
bleeding associated with the radial site. Hence the majority of bleeding occurred with femoral 
access route procedures, a finding consistent with other studies (Cox et al., 2004; Kiemeneij, 
Laarman, Odekerken, Slagboom, & van der Wieken, 1997; Mamas et al., 2013). 
 
The reduced risk of bleeding complications in radial access procedures is likely to have 
similar reasons to the reduction of other complications, and includes closer proximity of the 
radial artery to the skin surface, and hence potential easier arterial puncture and 
haemostasis, and easier visual inspection and control of the radial site compared to femoral 
sites. 
 
This finding is important as it somewhat allays the fears of the clinical team when high risk 
patients are undergoing procedures via the radial artery. Patients who are at higher risk of 
bleeding complications, such as rescue PCI post thrombolysis, same-day administration of 
subcutaneous low molecular-weight heparin, patients who have continued warfarin therapy, 
or those on GP IIb/IIIa inhibitor infusions may still have procedures without the staff fearing 
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catastrophic bleeding complications for these very high risk patients, as would be the case 
via femoral access.  
 
5.4 Bruising 
Bruising was the most common observed complication with 44.6% of patients having 
experienced bruising following coronary angiography and PCI. This finding is consistent with 
previous research suggesting bruising occurs relatively frequently, with bruising occurrence 
reported between 5.1% and 68.6% (Cheng et al., 2013; Cosman et al., 2011; Duffin et al., 
2001). The majority of bruising in the study reported here was classified as small (20% of 
patients), with moderate bruising occurring in 10.2% and large bruising in 14.3% of patients. 
Although the majority of prior studies have not reported bruising size, two studies are 
noteworthy. Wilde et al. (2006) reported small bruising (< 2.5cm) in 18%, moderate bruising 
(2.5-7.5cm) in 16%, and least frequently, large bruising (> 7.5cm) in only 0.4% of patients. 
This contrasts with the findings of Cosman et al. (2011) who reported large bruising (>  
7.5cm) being most common in 33% of patients, followed by small bruising (≤ 5cm) in 26% 
and  moderate  bruising (5-7.5cm) in 11% of patients. However, the study populations of 
Wilde et al. (2006) and Cosman et al. (2011) were much smaller (n=57 and n=172 
respectively) than the current study’s research population (n=3,793). Differences in study 
design that may have accounted for variations in the incidence of complications include 
different study populations (stable and low risk day-only iliac or femoral angioplasty or 
stenting, versus elective coronary angiography and PCI) and telephone contact the day 
following the procedure (Wilde et al., 2006) compared to 5- 7 days (Cosman et al., 2011). 
 
Female gender was an independent predictor of bruising which is consistent with two 
previous reports (Cheng et al., 2013; Cosman et al., 2011). Cheng et al. (2013), in a study of 
85 patients, reported that females were more than 6 times more likely to develop bruising 
than men in diagnostic angiography and PCI via the radial route. Cosman et al. (2011) also 
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reported that female gender was an independent predictor of bruising in their study of 172 
patients (Cosman et al., 2011). Both of these studies had small sample sizes, hence this 
research adds more robust evidence that females are more likely to experience bruising 
following coronary angiography and PCI. The increased risk of bruising in females is not well 
understood. Cheng et al. (2013) proposed bruising is related to a higher incidence of 
bleeding in females during the haemostasis period (consisting of gradual TR bandTM 
deflations), resulting in re-inflation and subsequent prolonged compression at the radial 
puncture site. However this is unlikely to be the only causative factor as female gender was 
independently associated with bruising in the study reported here. 
 
In the study reported here, 91.3% of patients with bruising received antiplatelet, 
anticoagulant or thrombolytic medications, and previous research suggests females may be 
more at risk of bruising than men when taking these medications. A study of fall-related 
major haemorrhagic injury (including bruising) in persons taking antithrombotic medications 
found females were at an increased risk, but the reasons for this remain unclear (Bond, 
Molnar, Li, Mackey, & Man-Son-Hing, 2005). Future studies could focus on the cause of 
increased bruising among females and strategies for prevention. 
 
Patients undergoing a Primary PCI procedure for acute myocardial infarction were 
significantly more likely to have bruising complications compared to a diagnostic 
angiography procedure alone. Other studies have not indicated Primary PCI in particular to 
be associated with bruising, although having an emergency indication for a procedure (which 
includes Primary PCI) has been previously found to be independently associated with 
vascular complications (Tavris et al., 2005). Patients requiring Primary PCI may have more 
intense and rapid antiplatelet regimens than angiography alone and contribute to an 
increased risk. There may be other procedural factors in Primary PCI that have not yet been 
identified in the literature as associated with bruising, such as longer length or complexity of 
97 
 
procedure, that provide further areas for investigation into risk factors bruising for Primary 
PCI patients. 
 
Left sided arterial access was significantly associated with the occurrence of bruising 
complications in patients compared to the usual right sided access. This finding has not 
previously been reported specific to bruising complications. The uncommon angles required 
for arterial puncture by the proceduralist accessing the left femoral or radial artery may result 
in longer arterial access entry times, unfamiliar anatomy and potentially predispose the 
patient to increased bruising risk.  
 
Patients requiring more than one arterial puncture were significantly more at risk of 
developing bruising complications than one arterial puncture alone. Multiple punctures were 
independently associated with other peripheral vascular access site complications, however 
no previous studies have reported this association. It is possible that difficult arterial access 
requiring multiple attempts to access the arterial lumen may lead to extraluminal bleeding 
and subsequent bruising. Bleeding may also occur if manual compression between access 
attempts is inadequate. 
 
Patients with a SBP ≥ 140mmHg pre arterial sheath removal had an increased risk of 
developing bruising. Hypertension in the pre sheath removal period has been reported to be 
associated with peripheral vascular access site complications (Andersen et al., 2005; 
Dumont, 2007; Liew et al., 2007), although is not previously reported to be associated 
specifically with bruising. Excessive pressure loading on an unstable arterial puncture site is 
a possible mechanism for the increased bruising observed in the post procedure period for 
higher pre arterial sheath removal blood pressures (Moscucci et al., 1994), but further study 
is required to confirm if this is a key contributor. Controlling blood pressure pre sheath 
removal would seem an important strategy to potentially reduce bruising complications. 
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Patients with diabetes had a lower risk of developing bruising than those without. While 
diabetes has not been previously associated with either an increased or reduced risk 
following coronary angiography or PCI (Botti et al., 1998; Cheng et al., 2013; Cosman et al., 
2011; Pracyk et al., 1998; Sabo et al., 2008), patients with diabetes appear to have lower 
risk of bruising that is unrelated to invasive procedures. The risk of nuisance bleeding 
(defined as easy bruising, bleeding from small cuts, petechia and ecchymosis) in the first 
year following drug eluting stent implantation was lower for those with diabetes, however the 
study aim was to determine the impact of longer-term dual antiplatelet therapy and not 
directly related to peripheral vascular access site complications (Ben-Dor et al., 2010). 
 
The proposed mechanism for the reduced risk of bruising for patients with a history of 
diabetes is likely to be similar to that of haematoma, where a prothrombotic state may be the 
mediating factor. However further research is required to explain this association between 
diabetes and the risk of haematoma. 
 
Patients who had a previous angiogram or PCI were at less risk of developing bruising 
complications. This finding has not been reported elsewhere in the literature although 
previous procedures have rarely been studied as a possible predictor of bruising 
complications (Botti et al., 1998; Pracyk et al., 1998). Botti et al. (1998) found repeat femoral 
puncture in the past three months had no effect on the incidence of femoral bleeding or 
bruising. As discussed in relation to haematoma risk in these patients, it is possible that 
patients gain experience from past procedures on access site self-care.  
 
Radial artery access was associated with less bruising compared to femoral access with a 
54% lower risk for patients. This reduced risk of bruising with radial access procedures has 
not been reported in the few studies reporting bruising in radial and femoral access 
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procedures (Cosman et al., 2011; Ludman et al., 1997). Several mechanisms may explain 
the reduced risk of bruising in radial access procedures. The radial artery is easily palpable 
and close to the skin surface compared to the femoral artery which is located deeper and 
hence the radial artery is potentially easier to access. Less subcutaneous tissue damage 
may result in reduced bruising at radial sites. Bleeding and haematomas occurring at the 
radial site are easily recognised and controlled, and therefore may lead to less bruising. 
There is less subcutaneous space for haematomas within the wrist and arm area compared 
to the femoral access site which can harbour several litres of blood and lead to extensive 
bruising.  
 
Another possible mechanism has been suggested by Azzalini and Jolicoeur (2014) as a 
radial paradox in the current era, where training physicians have gained skills in coronary 
angiography and PCI in an environment where radial access is more commonly used than 
femoral access for procedures. A subsequent lack of mastery in this area might lead to 
higher than previously reported femoral vascular complication rates. 
 
The current study revealed that bruising was less prevalent in 2012 compared to five years 
earlier with a reduction of moderate to large bruising from 30.7% to 14.5% in this timeframe. 
This finding has not been reported previously with no studies reporting temporal trends in 
bruising following coronary angiography or PCI. The decrease in bruising during the study 
period was independent of the increase in radial access and decrease in femoral access 
procedures. Factors such as a decrease in the earlier intense antiplatelet and anticoagulant 
regimens do not fully explain the decrease in bruising as these medications were not 
associated with bruising in this study. Procedures have not noticeably changed with 
Advanced Trainees performing the vast majority of sheath insertions and RNs removing the 
majority of sheaths. Advanced Trainees rotate continually over a 3-year period where the 
study was conducted. It is possible that Cardiologists and CAU RNs have gained significant 
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experience over this period of time, leading to the observation of fewer complications. It may 
also be that technical advances, not measured in this study over the study timeframe have 
contributed to this observation. 
 
Overall, this study is the largest study reporting both frequency of and predictors for bruising 
to date. Nine variables were independently associated with bruising accounting for 9.5% of 
the variance, suggesting there are still many other unmeasured factors associated with risk 
of bruising to be determined in future research.  
 
5.5 Rare complications 
Rare complications (retroperitoneal bleeding, pseudoaneurysm, arteriovenous (AV) fistula, 
complications requiring vascular surgery and infection) occurred in 1% of patients following 
coronary angiography or PCI, confirming they occur very infrequently. This is consistent with 
other studies reporting rare complications including retroperitoneal bleeding (0-2%) 
(Boztosun et al., 2008; Buchler et al., 2008), pseudoaneurysms (0-5.6%) (Kussmaul 3rd et 
al., 1996; Moscucci et al., 1994), AVF (0-1.5%) (McCabe et al., 2001; Moscucci et al., 1994), 
complications requiring vascular surgery (0-7.6%) (Buchler et al., 2008; Moscucci et al., 
1994) and infection (0-1.5%) (Carere et al., 1998; Eggebrecht et al., 2004). 
 
In this study, females had almost three times the risk of developing rare complications when 
compared with males. This finding is consistent with other studies reporting the higher risk of 
females in developing rare complications. All of the patients in the current study with 
retroperitoneal bleeding were female, suggesting female gender was an important factor in 
the development of this complication. In other reports, females are more likely to have 
retroperitoneal bleeding specifically (Ellis et al., 2006; Farouque et al., 2005; Kent et al., 
1994) and were more at risk in studies reporting general vascular complications, including 
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retroperitoneal bleeds (Doyle et al., 2008; Piper et al., 2003; Tavris et al., 2004; Yatskar et 
al., 2007). 
 
Females are more likely to develop pseudoaneurysms (Johnson et al., 1994; Knight et al., 
2003; Moscucci et al., 1994), and while there were no AV fistulas reported in this study, 
female gender has been associated with AV fistulas previously (Perings et al., 2003).  
 
The increased risk of rare complications in females is not well understood. In retroperitoneal 
bleeding, various gender-specific factors may exist such as smaller diameter and shorter 
length of common femoral arteries (Schnyder, Sawhney, Whisenant, Tsimikas, & Turi, 2001) 
resulting in more difficult “ideal landing zones” for arterial puncture and an increased risk of 
multiple or posterior-wall punctures. Hormonal differences such as effects of oestrogen on 
vascular function, menopausal changes in coagulation and fibrinolysis and increased 
pulsatility related to body size have been proposed as possible mechanisms increasing the 
risk in females (Farouque et al., 2005). Similar gender-specific factors have been proposed 
in the development of rare complications such as pseudoaneurysm and AV fistula (Knight et 
al., 2003; Perings et al., 2003). 
 
The majority of rare complications experienced by females in this study occurred before 
2010, with no rare complications in females in 2011 or 2012. While year of procedure was 
not associated with rare complications in this study, others have indicated a decreasing risk 
for women from the 1990s to the 2000s, both for retroperitoneal bleeding (Doyle et al., 2008) 
and for vascular complications generally (Applegate et al., 2008). 
 
5.6 Clinical implications of findings 
Haematomas, bleeding and bruising are relatively common complications following coronary 
angiography and PCI, and while some complications may initially seem innocuous, or even 
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unexpected, these complications can be clinically important and also of great concern for 
patients. 
 
Complications such as significant haematomas and bleeding indicates a loss or absence of 
haemostasis, which requires immediate actions to prevent progression, stop bleeding 
external to the arterial lumen and to reduce the likelihood of further clinical deterioration. 
Femoral haematomas may be difficult to detect and become quite large with a significant 
drop in haemoglobin with up to 500mls of blood lost, especially in the obese or in patients 
with large thighs (Kern, 2011, p. 63). Haematomas and bleeding are traditionally treated with 
mechanical force i.e. compression in the form of manual pressure or with devices such as 
FemoStopTM to achieve haemostasis. Regaining haemostasis in the setting of an underlying 
haematoma is often a painful experience for patients, with pressure applied over the 
haematoma and the potential for subsequent vasovagal reaction. 
 
Early identification of small haematomas is important to prevent the development of large 
haematomas leading to serious clinical sequelae. Patient education is important following 
haemostasis so patients receive instructions to reduce the possibility of developing 
complications such as haematomas, including (among other things) keeping the punctured 
leg straight, keeping the head down and holding the groin site when coughing, sneezing or 
laughing (to avoid placing additional pressure on the site); and staying in bed and calling a 
nurse for assistance if there is bleeding, swelling or pain (Kern, 2011, p. 63; Watson & 
Gorski, 2005, p. 254). Despite frequent observations and assessment by nursing staff, 
patients are educated to report these symptoms if they occur, and are in an ideal position to 
report these early.  
 
Patients can, however, be left feeling anxious with the volume of information that is new to 
them, the risk of complications and a sense of responsibility in having to speak up if signs of 
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a haematoma are noted. A qualitative study by Beckerman et al. (1995) using a 
phenomenological approach investigated the experiences of 10 male patients undergoing 
their first cardiac angiography. While the fear of the possibility of developing complications 
did not feature highly, one patient felt isolated after the test stating:  
“when you get back to the room, you have a fear of moving. They instil that fear of 
not moving the leg and keeping completely immobile. Fear that I might blow out an 
artery. It was a little rough, trying to deal with everything by myself. I didn’t much care 
for that” (Beckerman, Grossman, & Marquez, 1995)(p.217). 
 
Patient anxiety in the pre-, intra- and post-procedure periods of coronary angiography and 
PCI may also affect a patients’ ability to focus on information being provided to them by 
health professionals regarding aspects of their care. Patients may be given a large volume of 
information very early in the recovery period. Information from medical staff includes 
procedure results and future plans, medication changes and follow-up appointments. 
Nursing staff provide information regarding observations, haemostasis, mobilisation, risk 
factors, recovery and discharge plans and, of course, signs and symptoms of complications 
such as haematomas. Anxiety may affect a patient’s capacity to process and retain 
information provided by nurses (Bone et al., 1995). Nurses should consider this possibility 
when giving instructions about mobilisation protocols, access site care and monitoring and 
actions related to access site complications such as haematoma.  
 
Bruising complications occurred in nearly half of the patients in this study and it is the largest 
study to date reporting this complication. Bruising is important to patients as not only can 
patients find it “shocking” (Page, Jackman, & Snowden, 2008), but bruising has the potential 
to affect patient compliance with important antiplatelet medications (Roy et al., 2008). In 
attributing “nuisance bleeding” such as bruising to antiplatelet medications such as aspirin or 
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clopidogrel, patients having PCI procedures may be at risk of ceasing these medications, 
leading to stent thrombosis and affecting long-term prognosis (Roy et al., 2008). 
 
Bruising may also be a surrogate measure of other complications such as bleeding or 
haematomas which then result in bruising, rather than measuring independent risk factors 
causing bruising alone. Bruising has been associated with the presence of vascular 
complications pre sheath removal (Chlan et al., 2005) and also with the occurrence of 
immediate bleeding post sheath removal (Thore et al., 2001). 
 
This study found patients with a history of previous coronary angiography or PCI were 
associated with less risk of haematoma and bruising complications. Past experiences of 
coronary angiography or PCI procedures may provide an opportunity to accumulate 
knowledge regarding post-procedure care and complications, thereby developing self-care 
skills that may contribute to the prevention of various peripheral vascular access site 
complications. Information provided to patients regarding the procedure, aftercare, 
mobilisation protocols and possible complications can be extensive and therefore quite 
daunting. It is important for nurses to have an understanding of their patient’s previous 
experiences and background and tailor information and instructions according to individual 
needs. Conversely, for patients having their first angiogram or PCI, targeted education on 
the identification, self-care and early reporting of complications is important to reduce their 
risk. 
 
The increase in radial access procedures worldwide has resulted in fewer vascular access 
site complications and also a noteworthy effect on patient expectations. Patients are often 
told of the benefits of radial procedures from medical staff, nurses, other patients, friends 
and family and also from the internet. An expectation that all patients should have access to 
radial procedures may be unrealistic. 
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The complete abolition of complications is an impossible achievement in view of the invasive 
nature of coronary angiography and PCI procedures. However, identification of patients who 
are at increased risk for particular complications allows medical and nursing staff to employ 
strategies to reduce the risk. Increased vigilance in the monitoring of patients at higher risk 
may help to decrease the incidence or severity of the occurrence of complications. Arterial 
access site management includes regular observations and nursing care as essential feature 
in the early identification and prevention of complications. 
  
Active employment of risk-reducing strategies may be possible for some but not all patients. 
As radial access was the strongest predictor of lower complications, radial access should be 
considered for patients at higher risk of complications. However in reality, this is not always 
possible with only 40% of procedures being radial procedures. Radial artery access 
contraindications include larger guiding catheter size requirement for complex procedures, 
extreme tortuosity or loops (radial, brachial or subclavian arteries), severe arterial spasm, 
bypass graft take-off or anatomy that requires femoral access, etc. (Kern, 2011, p. 38). 
Proceduralist preference for femoral procedures (or lack of radial access training) also 
prevents patient access to radial procedures. Nevertheless, radial access is increasing and 
improved access to radial procedures is possible.  
 
The number of risk factors in this study that were independently associated with 
complications allows for the potential future development of predictive risk scoring models. 
Others have developed risk-reducing models to predict an individual’s risk for the most 
severe bleeding complications and the model aims to optimise therapy in higher risk patients 
(Mehran et al., 2010; Nikolsky et al., 2007; Pocock et al., 2010). However, these models 
were derived from the ACUITY, HORIZONS-AMI, REPLACE-1 and REPLACE-2 studies with 
all of these interventional studies involving various antithrombotic regimens, contained 
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numerous exclusion criteria and defined major bleeding in most severe terms (intracranial 
bleeding, intraocular bleeding, access site haemorrhage requiring intervention, etc.). There 
is no risk scoring model available to predict broader complications such as haematoma, 
bleeding, bruising or rare complications as defined by the study reported here. 
  
5.7 Implications for future research 
Continuous quality projects, such as the one reported in this thesis, allow for the ongoing 
monitoring of peripheral vascular access complication rates, for benchmarking to ensure 
compliance is within incidences reported elsewhere. It is important that this type of quality 
data collection continues to ensure complication rates remain monitored and kept as low as 
possible. The ongoing evaluation of the factors associated with peripheral vascular access 
site complications allows review of practices that may contribute to complications with 
ongoing monitoring providing opportunities to improve practice using the quality cycle. 
 
This study is the first to report diabetes as being associated with fewer bruising 
complications following coronary angiography and PCI. While possible mechanisms have 
been proposed, further research into the role of diabetes in the reduced development of 
peripheral vascular access site complications is important. 
 
Consideration should be given to future potential interventions to reduce patients at risk of 
developing peripheral vascular access site complications. Potential interventions may 
include: x-ray screening or ultrasound to facilitate arterial access to reduce the risk of 
multiple punctures; targeted reduction of a patients SBP pre sheath removal; and earlier 
sheath removal following procedures.  
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This study has identified many demographic, clinical factors, pre-procedural and procedural 
factors associated with the development of peripheral vascular access site complications in 
patients following coronary angiography and PCI. The development and validation of risk 
scoring models for developing clinically significant bruising, would enable the identification of 
those patients most at risk and thereby offer potential to reduce complications in high risk 
patients. 
 
5.8 Strengths and limitations 
In this study, peripheral vascular access site complications in a single public hospital was 
investigated and therefore the findings reported here may not be generalisable to other 
patient populations. A major strength of this study is that it provides a contemporary 
reporting of complications rates for patients undergoing coronary angiography and PCI in the 
Australian context, and the findings are from a population ranging from low risk outpatient 
angiograms to high risk post thrombolysis STEMI patients. 
 
Rare complications were combined in this study for statistical analyses due to low numbers 
of reported complications and may have diluted the significance of specific predictors for 
individual complications. 
 
There were several possible limitations in the study design related to the collection and 
reporting of data. The definition of a bleeding complication was subjective and difficult to 
quantify objectively when not related to measurable criteria such as drop of haemoglobin or 
haematocrit, or administration of blood products. In-hospital complications were reported by 
nursing staff in various departments and it is possible that some complications were 
underreported. Despite an 83.6% follow-up phone contact rate, some post discharge 
complications may have been missed, including a small number of patients who may have 
died following discharge. As such, these findings may only be interpreted as complications 
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identified in those who were successfully followed- up. Some complications such as 
pseudoaneurysm and AV fistula are difficult to diagnose following discharge without physical 
examination and further testing, and so reported rates may be underestimated. 
 
It is possible that unmeasured factors may have contributed to the occurrence of vascular 
access site complications. Higher activated clotting time (ACT) during PCI (Brener et al., 
2004; Hillegass et al., 2002; Tolleson et al., 2003) or pre arterial sheath removal (Andersen 
et al., 2005), have been associated with bleeding complications. Local practices did not 
include the routine collection of ACTs during PCI or prior to arterial sheath removal. ACTs 
were performed rarely and when ordered by a Cardiologist. Local policy directed sheath 
removal to occur when the ACT was less than 150 seconds in patients who had an ACT 
performed. If the ACT was greater than 150 seconds, it was repeated hourly until the ACT 
was less than 150 seconds. ACTs were not documented as part of this study and ACT-
guided sheath removal may have reduced the occurrence of peripheral vascular access site 
complications such as bleeding. Nursing Clinical Practice Guidelines developed in Australia 
by Rolley et al (2011), provided similar recommendations (for sheath removal when the ACT 
is less than 160 seconds), however the authors identify a lack of evidence for the efficacy of 
performing ACTs to guide sheath removal. ACTs may have little impact on vascular 
complications in radial access procedures as arterial sheaths are routinely removed at 
completion of the procedure and level of ACT has been shown to have no effect on bleeding 
complications rates (Bertrand et al., 2009). 
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Chapter 6 – CONCLUSION 
 
6.1 Introduction 
In this thesis the results of an evaluation of the incidence of peripheral vascular access site 
complications following coronary angiography and PCI are reported. The study focused on 
complications such as haematoma, bleeding and bruising, retroperitoneal bleeding, 
pseudoaneurysm, AV fistula, infection and complications resulting in vascular surgery. This 
study also explored the relationships between demographic, clinical factors, pre-, intra- and 
post-procedural factors and the occurrence of complications. 
 
As identified in Chapter One, coronary heart disease is the leading cause of cardiovascular 
deaths in Australia and while mortality rates are decreasing, invasive coronary angiography 
and PCI procedures have steadily increased. Population predictions forecast the growth in 
the proportion of older persons and hence there will be a continued demand for coronary 
angiography and PCI in the future. Coronary angiography and PCI procedures involve 
accessing the arterial system, and these procedures evolved from surgical cut-down to 
percutaneous techniques. While the brachial artery was the original arterial route, this was 
surpassed by femoral access for several decades until more recently the radial artery has 
gained increasing popularity. Arterial access however, is not without risk. Peripheral vascular 
access site complications following coronary angiography and PCI have been extensively 
reported over the past few decades, however are less understood in the Australian context. 
 
In Chapter Two, the prevalence of peripheral vascular access site complications including 
haematomas, bleeding, bruising, retroperitoneal bleeding, pseudoaneurysm, AV fistula, 
complications resulting in vascular surgery and infection are discussed in detail. As 
procedures evolved and became increasingly complex, vascular complications also 
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increased in prevalence. Risk factors contributing to vascular complications were identified 
and discussed.  
 
In Chapter Three, the study design is described; a retrospective evaluation of patients who 
underwent diagnostic coronary angiography or PCI at a local hospital. Data analysis was 
outlined in the context of the variables collected and the peripheral vascular access 
complications defined. 
 
6.2 Summary of findings 
As described in Chapter Four, peripheral vascular access site complications are relatively 
common occurrences with almost half of the patients in the study reported experiencing 
some complication. Bruising was the most common complication (44.6%), followed by 
haematoma (15.5%) and bleeding (9.5%). Rare complications identified included: 
retroperitoneal bleeding, pseudoaneurysms, complications resulting in vascular surgery, 
access site infection and AV fistulas. Such complications accounted for a combined 
incidence of 1.02%. 
 
Assessment of demographic factors revealed the only significant factor associated with 
vascular complications was female sex, contributing to an increased risk of haematomas, 
bruising and rare complications. Of the clinical history variables associated with 
complications, a history of hypertension was associated with bleeding and both diabetes and 
a history of previous coronary angiography or PCI were associated with fewer haematoma 
and bruising complications. The majority of medications were not associated with vascular 
complications with the exception of aspirin and tirofiban that was associated with developing 
haematoma. 
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Assessment of procedural factors revealed several important associations with various 
peripheral vascular access site complications.  PCI procedures were associated with 
increased risk of bleeding and bruising, left sided arterial access was associated with 
increased bruising and multiple punctures was associated with haematoma and bruising. 
Bleeding and bruising complications decreased over the study period from 2007 to 2012.  
Radial arterial access was associated with fewer haematoma, bleeding and bruising 
complications compared to femoral access. 
 
Post-procedure factors associated with vascular access site complications revealed pre-
sheath removal SBP ≥ 140mmHg was associated with increased haematomas and bruising, 
and longer sheath dwell time was associated with increased bleeding. 
 
Coronary angiography and PCI procedures have increased in number in Australia and are 
well tolerated by most patients, however they are invasive procedures and not without risk. 
Peripheral vascular access site complications occur relatively frequently following coronary 
angiography and PCI and while major complications are reassuringly rare, they are 
important to patients. Previous research has been directed towards complications such as 
haematomas, bleeding and the various rare complications, and this study has further 
contributed to what is known about these complications. Less is known about the risk factors 
for bruising complications that patients may find as equally important as other complications, 
and this research provides insight into the frequency and factors that contribute to bruising 
following coronary angiography and PCI. 
 
While some risk factors for complications are non-modifiable (including female sex) and 
some are generally acceptable as they are necessary in the treatment of coronary disease 
(e.g. aspirin), several risk factors are modifiable and more can be considered to actively 
reduce patient’s risk of developing complications. Arterial access via the radial route is a 
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recent and important practice change and this study confirms the reduced risk of radial 
access in many access site complications. Diabetes was associated with a lower risk for 
several complications and has not been previously reported and requires further 
investigation. 
 
In conclusion, the information presented in this thesis makes a unique contribution to 
research surrounding peripheral vascular access site complications following coronary 
angiography and PCI, especially in the Australian context. The results from this evaluation 
provides insight into the frequency and risk factors for complications, and although serious 
complications were observed to be rare, less serious complications appear relatively 
common and are likely to be of great significance for patients undergoing future procedures.
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